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Abstract 
CONTEXT: Current practices of outpatient care for type 2 diabetes are not 
producing adequate patient-oriented outcomes according to the targets established 
by clinical research trials. OBJECTIVE: To systematically review the best 
evidence available about the care of diabetes in the outpatient setting. 
METHODS: The author searched both the PubMed and CINAHL databases for 
reports of randomized controlled trials and systematic reviews published in 
English between 2001-2005 that matched the MeSH terms "diabetes" and 
"outpatient". Articles were then narrowed based on both relevance and quality. 
Included studies reported patient-oriented outcomes (blood pressure, percent 
hemoglobin A1c, or blood lipid levels). Interventions were divided into those 
affecting the setting of care, affecting the process of care, or involving primarily 
education. RESULTS: Of441 identified articles, 19 met all criteria and were 
included. Intensive process interventions were effective and generally involved 
multifaceted case management. Educational interventions were effective in the 
short term, but benefits did not extend beyond the intervention term for any study. 
Setting interventions showed no significant benefit. CONCLUSIONS: The 
literature on this topic is still inconclusive and heterogeneous. The few 
interventions that showed benefit are highly resource-intensive, and for this 
reason have significant threats to broad applicability. Successful process 
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interventions require cost-benefit studies to determine their widespread feasibility 
in varied settings. Neither setting nor education interventions show physiological 
benefits that justify their cost. 
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Introduction 
Type 2 diabetes mellitus is a chronic disease with significant associated 
morbidity and mortality. In the United States, prevalence of diagnosed diabetes in 
adults has increased rapidly over the last three decades from 1.8% in the early 
1960s to 5% in 1999-2000. Although some ofthis trend certainly derives from 
increased detection, the estimated prevalence of all diabetes including 
undiagnosed disease has risen from 5.3% to 8.1% of US adults1 '2 
People with diabetes have excess all-cause mortality, and increased 
mortality from specific causes, especially cardiovascular disease3 ·5 In addition, 
diabetic patients suffer considerable morbidities. Diabetes is a leading cause not 
only of cardiovascular and stroke morbidities, but also blindness, end stage renal I disease, and lower extremity amputation 6 
Despite the tremendous burden of the disease, the progression of diabetes 
is not inexorable and can be significantly slowed. Tight glycemic control has 
been shown to reduce the microvascular complications of type 2 diabetes, and 
may reduce macrovascular complications as well.7' 8 Other interventions that may 
be helpful are controlling blood pressure 9, controlling lipids, 10• 11 improving foot 
12 d l . "' . h 12 care, an regu ar screemng tOr retmopat y. 
Despite the recognition that tight control of glycemia and other risk factors 
is very likely to improve diabetes outcomes, glycemia in people with type 2 
diabetes often remains uncontrolled. A 1999 study of people with diabetes in the 
US found that over one third had HbA1c values >8.0%.13 After a decrease of 
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nearly half between 1971 and 1988, the proportion of people with diabetes and 
comorbid hypertension (blood pressure > 140/90) was static at about 35% from 
1988-2000, and may be rising. 14 
Given such evidence, there is apparent room for improvement in the 
management of type 2 diabetes, particularly in the outpatient management setting. 
Although the future may hold advances in pharmacology, currently available 
agents have been shown to produce target reductions in hemoglobin A 1c (HbA1,)/ 
blood pressure, 15 and lipids16 Medical care has not yet fulfilled the promise 
toward which the experimental data have pointed, namely improved glycemic 
control and reduction of vascular risk factors resulting in a widespread reduction 
in morbidity and mortality for patients with type 2 diabetes. 
Because effective pharmacologic agents and behavioral interventions are 
already available to control glycemia and mitigate vascular risk factors, the 
challenge may be primarily to improve the way providers assess and reduce risks 
in the outpatient settings. The objective of this paper is to systematically review 
the literature addressing this approach in the care of adults with diabetes. Because 
a Cochrane review on a similar topic was published in 2000, this update includes 
only reports published more recently (in years 2001-2005) for review. 
The specific question that this review attempts to answer is : "What types 
of non-pharmacological interventions, if any, have been shown to improve 
patient-oriented clinical outcomes for adults with type 2 diabetes?" I have divided 
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the interventions into three categories: those involving the setting of care, 
involving the process of care, and involving educational interventions. 
Changes in the setting of care may have a different focus of care (e.g. 
diabetes specialty clinics) or may involve different types of providers in diabetes 
care (e.g. nurse-led clinics). Rather than slightly altering the "usual patient visit", 
the entire setting of care is different in the intervention group, including the 
physical location of the clinic. 
In contrast to changes in the setting of care, process interventions change 
only one or two aspects of the usual patient visit, e.g. adding routine 
psychological monitoring of patients with diabetes. The difference in scope 
between process and setting interventions is substantive, and by looking at each 
type separately we may better understand whether wholesale changes in diabetes 
care are necessary, or whether smaller adjustments can have important effects. 
Finally, educational interventions are primarily informational, and are 
often aimed at improving patients' care of themselves when they are away from 
the medical office. The rationale for such studies is rooted in the concept of self-
care, wherein the patient herself is responsible for most day-to-day care in a 
chronic illness like type 2 diabetes, an idea explained by Glasgow et al. in 199917 
and further elucidated by Bodenheimer et al. in 2002. 18 Educational 
interventions build on this conceptual framework by aiming to increase patients' 
ability to manage their disease. 
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This classification system is imperfect; some studies may involve multi-
level interventions that do not neatly fit into one or another of these categories. If 
there was a single dominant intervention, I considered the study within the 
category that fits that intervention. If there were many interventions using many 
methods studied together, I considered the study to represent an effective change 
in the setting of care, and considered it alongside other studies of that type. 
Some interventions that are not themselves expressly pharmacological are 
implemented with the primary goal to support pharmacology, e.g. to improve 
adherence to drug regimens. Although these may be very valuable, their 
essentially pharmacological nature leaves them outside the scope of this review. 
Patient-oriented clinical outcomes include those physiological outcomes 
I which have been significantly associated with physical complications of type 2 
diabetes. Specifically, major outcomes of interest include percent glycosylated 
hemoglobin (HbA1,) as a measure of glycemic control, hypertension (HTN), and 
blood lipids, including total cholesterol and low-density lipoprotein (LDL). 
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Methods 
Before beginning the search process, the author established inclusion and 
exclusion criteria for articles in the current review (Table 1 ). Included articles 
focused on type 2 diabetes in adult outpatients. Articles focusing only on type 1 
diabetes were explicitly excluded because the differences in the underlying 
pathophysiology of the two types of disease dramatically affect the types of 
intervention which should be primary (i.e. exercise and diet in type 2 diabetes 
compared with insulin in type 1 diabetes). Such differences between the two 
types of disease may therefore affect the efficacy and effectiveness of many 
interventions, especially when benefits are relatively smalL 
Some studies included both types of diabetes or a wide range of patient 
ages. I included such studies for consideration if relevant age or disease-type 
subgroups composed at least 50% of patients. 
I pragmatically limited the review to articles published in English. 
Because a Cochrane review of high quality with a similar focus was published in 
late 2000, the current review encompasses only studies published in 2001 and 
later. 
I searched the PubMed and CINAHL databases for relevant articles using 
the terms "type 2 diabetes" and "diabetes" in combination with the terms 
"outpatient" or "ambulatory", with searches limited to human studies, English 
language, and publication in 2001 or later. The PubMed search yielded 382 
unique articles, with an additional38 titles identified in the CINAHL database. 
7 
Table 1: Inclusion and Exclusion Criteria 
' ' Excluded:\, ' ' ' Parameter 
' 
:::_ ',;,TI!eludeO! ~: ',, 
' ' 
Sample Size Greater than 20 subjects Less than 20 subjects 
Disease Type Type 2 diabetes in Studies of type 1 diabetes 
majority of patients OR only OR majority of 
type 2 cohort analyzed patients type 1 without 
independently separate analysis 
Age Adults > 18 yrs are Populations with 
majority of patients OR majority of children ( <18 
separately analyzed yrs) if adults are not 
analyzed separately 
Study Design RCT, meta-analysis Prospective cohort, 
retrospective cohort, 
cross-sectional, 
crossover, narrative 
rev1ew 
Outcomes Major outcomes include Major outcomes do not 
at least one of: BP, include any of the 
HbA1c, blood lipids parameters of interest 
Intervention Interventions that Interventions that are 
primarily alter the setting primarily pharmacologic 
or process of care, or are i 
educational 
Quality No major threats to Major threats to internal 
internal validity validity 
I initially sorted all abstracts for relevance, discarding clearly irrelevant 
articles. Examples of irrelevant articles are those which did not address diabetes 
at all, those which explicitly addressed only type I diabetes, those whose 
intervention was primarily pharmacological, and those which studied only 
children. 
I obtained full text copies for all articles deemed relevant in the initial 
search. I hand searched both the reference lists of full text articles and the January 
2001-June 2005 tables of contents of journals Diabetes Care andDiabetologia for 
additional studies that I missed in the electronic search. Hand searching yielded 
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21 additional studies. I evaluated all full text articles for relevance, study design, 
and quality. (Table 2) 
I have included only randomized, controlled trials (RCTs) in this review. 
The question of interest is whether specific interventions are effective in treating 
diabetes. Included studies must therefore be able to demonstrate causation with 
minimal confounding from other variables. When properly done, the RCT meets 
these requirements, because effective randomization creates comparison groups 
that differ only in their treatment allocation, theoretically eliminating the effects 
of confounders. Coupled with the prospective design, this allows us to draw the 
strongest conclusions about causation from RCTs. 
I excluded prospective cohort studies. This study type can sometimes 
provide clues to disease etiology when large RCTs are not practical or have not i 
been done. For studies of treatment, however, the use of non-random cohorts 
allows confounders to cloud the causal relationship between treatments and 
outcomes. I excluded retrospective cohort studies because they have the same 
weaknesses as prospective cohort studies with regard to confounding, and have an 
additional weakness in that the retrospective design gives investigators no control 
over selection or measurement biases. 
I did not consider cross-sectional studies or observational studies because 
they cannot demonstrate causal relationships between interventions and outcomes. 
I included meta-analyses of relevant topics if they made inferences about 
causation. I also excluded narrative reviews or reviews by expert panels that were 
not systematically conducted with explicit methodology. Such reviews have 
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tremendous potential for selection bias in the literature the authors choose to 
review, and do not allow the reader to adequately assess the quality of their 
methods. 
Table 2: Quality assessment in reviewed studies 
Quali~ Criterion ~ '·. . • Higl.je:r ~lity '!Bower Qua.ti.ty 
Group Allocation Computerized Not described OR 
randomization; inadequate method 
randomization by outside 
service; varied block 
sizes for block 
randomization 
Sarnp le size 30 or more <30 
Attrition rate <20% 20% or more 
Masking Masking of interested Unmasked investigators 
parties taking subjective taking subjective 
measures measures 
Measurement All outcome measures Nonstandard 
standardized measurement OR not I \ 
described 
Outcomes Predefined by Defined post hoc OR 
investigator before study; unwarranted novel 
standard, objective measures and indexes in 
measures and instruments place of more widely 
used measures OR use of 
non-validated measures 
and scales 
Confounding Adequate report of Failure to report any 
known potential information about 
confounders AND no potential confounders OR 
apparent confounding in reported confounders that 
selection, allocation, or are not accounted for in 
measurement the analysis or discussion 
External Validity representative sample of Unrepresentative sample 
target population AND OR highly selected target 
target population with population with 
similarities to likely characteristics difficult to 
external populations; replicate OR expensive 
intervention easily or difficult intervention 
applied in varied 
situations with minimal 
alteration 
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I assessed studies for quality using the form presented in the evidence 
table (Appendix 2). The assessment examined sample size, potential sources of 
bias, suitability of measured outcomes, and confounding. Each reviewed study 
was given one of three descriptors of overall quality (Poor, Fair, Good). Studies 
of poor quality had, in my judgment, overwhelming flaws in internal validity and 
were eliminated from further review (Appendix 3). I gave a rating of Fair quality 
to a study ifthere were potential threats to internal validity, but no clear flaw that 
could fully account for the reported outcome. Inadequate reporting of important 
methods (e.g. method of randomization) also resulted in a rating of Fair. I judged 
a study to be of Good quality if it did not to have significant threats to internal 
validity and fully reported all important methods. I included both Fair and Good 
quality studies in this review. 
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Figure 1: Flow Diagram for Study Selection and Inclusion 
3 82 articles 38 articles 21 articles 
identified via identified via identified via 
PubMED CINAHL hand search 
~ / 
441 unique articles 
identified 
401 articles 
rejected based on 
abstract 
40 abstracts 
reviewed 
21 articles rejected 
based on review of 
full text 
19 articles included in 
final review 
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Results 
Of the 441 unique articles I identified, I reviewed all abstracts. Of these, I 
reviewed the full text of 40 articles and accepted 19 into the review. The flow 
diagram for this process is summarized in Figure 1. Appendix 3 is a table of the 
excluded articles for which I reviewed the full text, with the reasons for their 
exclusion. 
Of the 20 reviewed articles, 2 involved setting interventions, 9 involved 
process interventions, and 8 involved educational interventions. Within these 
categories, the specific interventions were heterogeneous. Below is a brief 
summary of the reviewed studies by intervention category. More detailed reviews 
of the individual studies appear in Appendix I, and I present the evidence in 
tabular form as Appendix 2. 
Studies of Settings of Care 
Setting interventions are broad-based changes in multiple aspects of care 
delivery. I have included two studies of setting interventions in this review. 
Denver eta!. studied diabetes specialty clinics vs. usual primary care19 
Theoretically, a clinic whose processes and providers are focused on effective 
diabetes care will provide better processes and lead to better care. Denver et a!. 
reported a decrease in systolic blood pressure among patients using the diabetes 
specialty clinic, 19 but their result is confounded by a significant difference in the 
number of visits between the intervention and control groups. The other study of 
a setting intervention involved implementing structured diabetes care in general 
practice (GP) offices in Ireland. After 18 months of the intervention, none of the 
13 
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measured biophysical parameters, including HbA1,, blood lipids, or blood 
pressure, were significantly different between groups?0 
Studies of Processes of Care 
Process interventions were the most numerous group of studies, but also 
the most homogeneous. Of the 9 process studies included, 5 involved patient case 
management. Some ofthese interventions were intensive and broad, but they 
were all designed as supplements to primary care practice, not replacements, and 
therefore are process interventions. 
Four ofthe five studies of case management used HbA1, as a major 
outcome, and all found statistically significant changes favoring the intervention I I 21 .24 T f h d. . d "G d" 1· . groups over usua care. wo o t ese stu 1es receiVe oo qua 1ty ratmgs, and the other two had acceptable methods. The case management studies varied 
in duration of follow up, from one to three years. Studies reported changes in 
HbA1, ranging from 0.4% to 0.8% One study of case management used flawed 
statistics that potentially overestimated the decline in HbA1, by carrying forward 
early, steep declines in HbA1, when patients dropped out.21 
The single case management study that did not use HbA1, as one of its 
outcomes had two arms, one that intensively managed lipids and the other 
designed to manage blood pressure for patients in the UK. The results were 
reported as odds ratios, with OR=l.37 for patients to meet achieve treatment goals 
in the two clinics taken together, compared to usual care. The lipid clinic 
performed better on its own (OR 1.69), while the hypertension clinic, with a high 
dropout rate did not produce a statistically significant difference in the intention to 
14 
treat analysis. In this methodologically sound study, investigators found a 
significant mortality benefit, with the OR 0.55 in favor ofthe intervention 
25 group. 
There was a single included study of systematic, increased psychological 
monitoring in people with type 2 diabetes. Although the study was 
methodologically sound, and produced some small differences in psychological 
measures, there was no effect on HbA1c, the only measure included that is a major 
focus of this review.26 
DiLoreto et al. reported on an intervention that involved more intensive 
physician counseling for physical activity in people with type 2 diabetes in Italy. 
The intervention involves adding 30 minutes to the initial visit, following up with 
a 15 min phone call, and scheduling appointments every 3 months, with a focus 
on counseling patients about physical activity. The mean HbA 1c was significantly 
different between groups, at 7.0% for intervention patients compared to 7.6% for 
usual-care controls.27 This study was subject to internal validity problems, in that 
the investigators used a convenience sample of consecutive patients, and did not 
fully describe their randomization scheme. The primary outcome of the study, 
energy expenditure, was estimated from patient self-reports, but this flaw should 
not affect the glycated hemoglobin result. 
A different physical activity and nutrition intervention studied in rural 
Costa Rica also produced significant differences in HbA1c between groups. The 
Goldhaber et al. study combined weekly group nutrition classes with physical 
activity in walking groups 3 times per week over 12 weeks. Assessed 
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immediately following the intervention, the intervention group mean HbA1c 
decreased by 1.8%, while the control group mean increased 0.4%. A statistically 
significant difference in BMI also appeared (intervention -0.4kg/m2, control 
+0.2kg.m2), but blood pressure and blood lipids were unaffected28 This study 
was methodologically strong and the intervention relatively simple compared to 
other process changes, but the target population was very unusual and raises 
serious external validity problems. Rural Costa Ricans are unlikely to be similar 
even to rural populations in the US, except perhaps in areas with large numbers of 
patients with Central American origins and societal norms. 
The final included process intervention involved group chronic care visits 
in addition to standard primary care. Patients in a Seattle are HMO were recruited 
and randomized to the intervention or a usual care control. At 24 months the 
intervention group showed no significant differences from the usual care control 
in any biophysical parameter, including HbA1c or blood lipids. Investigators also 
looked at care utilization and found no differences between groups, although the 
intervention group contained fewer patients who self-reported more than I in-bed 
disability day. This study had several threats to its internal validity. Exclusion 
criteria were vague and seemed to allow arbitrary exclusion of patients by their 
physicians. To collect biophysical measures the authors relied on large HMO 
databases, which could lead to missed results. Perhaps most damaging, 65% of 
patients in the intervention group never attended a single group session, and all 
were included in the analysis. Even if the intervention is effective, a two-thirds 
crossover rate is likely to mask its benefit. 
16 
Studies of Educational Interventions 
Educational interventions include all patient education or instruction about 
diabetes care that does not occur during usual physician counseling in the course 
of a regular patient visit. I included 9 reports of educational interventions in this 
review29~37 There are 2 papers included in this section that are updates on cohorts 
whose initial reports are also included,32• 35 but I have grouped them to avoid 
confusion. 
The first educational intervention is the Diabetes Outpatient Intensive 
Treatment (DOlT) program, developed at the Joslin Diabetes Center and tested at 
a military hospital in Hawaii~ DOlT is both comprehensive and intensive, and 
requires patients to spend 3.5 full days in a row in the program being taught both 
didactics and practical skills. Afterward, case managers contacted patients 
quarterly by telephone, and met with one another weekly to discuss patient cases. 
All interventions carried forward through the six months until outcome measures 
were taken. DOIT patients had a significantly lower mean HbA1, (7.9%) thau the 
controls (8.7%) [p<O.OSJ at six months. Other measures of self-care were 
consistently better in the DOIT group30 However, the DOIT trial had some 
problems with internal validity. Patient dropout was differential, with mauy more 
controls (30%) thau intervention patients (9%) leaving the study. None of the 
dropouts' characteristics are given, and they are not included in the final analysis, 
raising a strong possibility of selection bias. 
Self-management education was the subject of three studies, of which two 
were reports on the same cohort and one was a meta-analysis of prior literature. 
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In 2002 Norris et al. reviewed the literature on self-management of diabetes, and 
produced a meta-analysis stratified by time of follow up. They showed that there 
is an important time effect in the literature in that investigators who measure 
outcomes just at the end of their studies often see benefits in terms ofHbA1,, but 
most benefits disappear in studies that follow up at 4 months or later after the 
intervention is over. 
Rachmani et a!. published two reports on the same Israeli cohort with type 
2 diabetes, hypertension (blood pressure > 140/90) and hyperlipidemia 
(LDL > 120mg/dL). The investigators randomized 141 patients to either the 
control group or the intervention. The intervention included a 90-minute teaching 
session in the diabetologist's office, at which they set goals, learned self-
management behaviors like managing medicine and exercise, and were I 
encouraged to follow up by telephone with the consulting physician when needed. 
The consultants saw the patients each for an hour visit annually thereafter, in 
addition to the care patients received from primary care physicians. 
At four years, reported in 2002, the intervention group had improved renal 
functioning, measured by e-GFR, compared to the control31 In 2005, an 8-year 
follow up on the same group showed that the intervention group had had fewer 
total nonfatal cardiovascular events (mainly strokes and myocardial infarction) 
than the control. 32 
Another educational intervention tried to demonstrate a difference 
between individual education and group education. An education center in 
Minnesota randomized 170 patients to either group or individual education, with 
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the intervention patients getting 5-7 hours of group education over 6 months, 
while the individual patients got 4 session of education over 6 months, which was 
roughly equivalent. The groups showed no significant differences in any 
parameter, but the intervention group's HbA1c values changed more than the 
control group's.33 However, this study was flawed in important ways. First, 
randomization was inadequate, not only because the method was sequential in 
blocks of three, but also because at baseline the groups were markedly different in 
the important parameter HbA1,, with the intervention group (baseline 8.9%) much 
higher than the control (baseline 8.0). There was also significant selection bias 
because of the high, differential dropout rate, which favored subjects' dropping 
out of the intervention group (overall dropout rate 46%, intervention group 
dropout rate 51%, control dropout rate 41 %). Finally, the larger drop in HbA1, in 
the intervention group is probably the result of the higher starting value, as both 
groups seem to have reached a floor of 6.5% by the end of the study. 
Another study of group education, done in Italy by Trento eta!., had a 
very different result. At 5 years the Italian studies report significant differences 
between groups at five years for %HbAlc (intervention= 7.3 ± 1.0, contro19.0 ± 
1.6; p < 0.001) and weight (intervention 76.1 ± 12.9 kg, control= 77.3 ± 16 kg; p 
= 0.015).35 The Italian intervention was similar to the Rickheim program, with 
four group education sessions delivered in each of the first two years, but the 
Italian study continued the groups, expanding to seven sessions in years 3 and 4 
before returning to 4 sessions in year 5. The Italian control was also different- it 
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was called "individual education", but referred only to normal counseling patients 
are supposed to get from their primary provider. 34 
A third study of group education from Sweden was focused on 
experience-based education. A specially trained pharmacist led group discussions 
with few didactics or "right answers", focused instead on sharing experiences and 
practical knowledge. The sessions occurred monthly for one year, with patient 
assessment occurring at 6, 12, and 24 months after baseline. The investigators 
found significant differences in mean HbA1c between groups at 6 and 24 months, 
but not at 24 months37 
There were significant issues with this study's internal validity. The 
randomization scheme was highly unconventional and apparently inadequate, 
producing a large difference in duration of disease between the two groups at 
baseline (intervention= 5.9 yrs, contro12.6 years). This highly selected cohort 
also had exceptional baseline control, with more than 50% of subjects having 
HbA1c < 6.5% at baseline. The power calculation does not support detection of a 
significant change in HbA1c ofless than 1% with their sample size of77. 
The final study of an educational intervention investigated whether 
cultural appropriateness could affect the success of an educational program in 
south Texas. The approach was intensive, with 3 months of weekly 2-hr 
instructional sessions, followed by 6 months of biweekly 2-hour support group 
sessions, which were followed by 3 months of weekly support sessions. Providers 
were bilingual and taught culturally appropriate modes of lifestyle management, 
e.g. cooking and shopping. The authors reported HbA1c and fasting plasma 
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glucose as being significantly different between groups based on a complex 
statistical model that extrapolates values for dropouts. This paradoxically 
confounds the result and leads to internal validity problems because HbA1, often 
drops most quickly in the early part of an intervention, and then levels off. The 
authors make no mention of accounting for this in their model, so we are left to 
assume they may have overestimated HbA1, improvement because of dropouts. 
In fact, the absolute values of all group mean HbA 1, were> 10% at the beginning 
and end of the study. 
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Discussion 
This review shows that interventions in outpatient diabetes care are 
heterogeneous in type and content. The most effective types of interventions 
were process interventions that involved case management, all of which reported 
some improvement in physiological outcomes. In contrast, changing the setting 
of care does not show a clear benefit over a usual care control. Educational 
strategies provide short-term benefits that have not been shown to persist beyond 
the term of the intervention. 
In 2000, Renders et al. published a detailed Cochrane Collaboration 
review of interventions to improve outpatient care for both type 1 and type 2 
diabetes.38 According to that review, the literature to that point was highly 
variable in both approach and quality. Briefly, Renders et al. concluded that 
multifaceted professional interventions and organizational interventions focused 
on prompting review of patients can enhance providers' management of diabetes, 
through improving process outcomes. Further, they found that patient-oriented 
interventions, especially those involving nurses in the intervention, could improve 
patient health outcomes. All the included interventions were multifaceted, 
involving more than one specific intervention. 
In general, the Renders et al. found that the methodological quality of the 
studies was frequently poor. Their included studies assessed process outcomes 
but infrequently assessed patient-oriented health outcomes. Further, follow up 
periods in the included studies were frequently brief, with the longest being 3 
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years and the shortest 4 months. Of the 41 studies included in the Cochrane 
review, 30 had follow up ofless than 2 years. 
This review is intended as an update on the literature in this area since the 
Cochrane review was published, in 2000. For that reason, I have forgone detailed 
descriptions of the studies that were included in that review.38 To provide the 
interested reader with a sense of that literature 1 have summarized the findings of 
the 27 RCTs included in the Cochrane review and included the summary as 
Appendix 4. 
Some of the trends noted in the 2000 Cochrane review have continued in 
the present review. The methodological quality of the studies I obtained for this 
review was very variable. As I noted in the Methods, I included only studies 
without serious flaws in internal validity in the text of this review, and noted 
excluded studies in Appendix 3. 
The modes of intervention are still heterogeneous, as Renders et al. 
reported in 2000. Even within interventions that are in the same class and are 
nominally the same, like "group education", the content of the interventions is 
widely variable. To economize research efforts, investigators in the future should 
consult the literature, including reviews like this one, and pursue lines of inquiry 
more closely in terms of method. The field currently has enormous breadth, but 
lacks much of the depth that is necessary to confidently implement changes in the 
average clinic. 
Changes in setting, despite the appeal of their premise, seem to offer little 
advantage in terms of clinical outcomes. The two studies included in this review 
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represent approximately 300 patients, and did not have serious methodological 
problems that could fully account for the negative findings. Given the expense 
and dismption involved in changing the complete medical setting, the benefits 
should be large to justify doing it. Those benefits are not apparent based on these 
studies. 
The most successful group of studies in terms of number, positive results, 
and strong methods, are the process studies involving case management. 
Conceptually these interventions are similar to specialty clinics, mainly because 
they share a holistic view of diabetes, and organize care to promote preventive 
processes. A major difference is that case management is strongly grounded in 
. 
the usual primary care setting. The responsibility for preventive care therefore ~ 
E 
shifts from the organization to a cooperative duty shared between the patient and i 
case manager. 
Case management does have questions that need to be resolved. First, the 
successful case management models presented in the studies here are exceedingly 
resource-intensive, particularly if they need to be sized up to practices with 
hundreds or thousands of patients with diabetes. These models generally require 
a trained counselor to be in routine contact with every patient in perpetuity. One 
research direction may be to gradually reduce the frequency of contacts to 
encourage more independent self-management, and make the manager an 
emergency resource for chronic patients. 
For process and setting interventions this review provides little 
information about long-term effects. Even the best studies rarely follow up 
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beyond the end of the intervention to see if the benefits persist. For a change of 
setting intended to be permanent this approach may not be logical, but the 
transition from case management to self management offers an example where 
such a study might be valuable. 
Educational interventions have done a better job trying to examine later 
outcomes, but the picture is mixed. The Rachmani eta!. studies show some long-
term effects, but supplemental instruction is ongoing throughout the follow up 
period. The Norris et a!. review shows clearly that the benefits of educational 
interventions wane over time. In this review, studies of educational interventions 
were often flawed in elementary ways, including subject selection and 
randomization. The studies that were methodologically adequate often either 
failed to produce acceptable levels of physiological parameters in any group, or I 
used such highly selected cohorts that baseline control was excellent, and couldn't 
show changes. 
Outpatient care for diabetes still has room to improve. We already have 
goals for many significant biophysical parameters that are likely to improve 
morbidity and mortality, but we need to figure out how to reach them in the broad 
cross-section of patients. The appeal of originality is undeniable, and we should 
always encourage and pursue tmly novel ideas. But we should also refine the 
techniques we already know to make them effective, practical, and proven enough 
to proliferate where more patients can benefit. 
25 
Appendix 1: Detailed Analyses of Included Studies 
Studies of Settings of Care 
DIABETES SPECIALTY CLINICS 
Denver eta/. (2003)- RCT in which the intervention consisted of a nurse-led 
clinic (NLC), compared with usual care (conventional primary care, CPC). 19 The 
study targeted 120 hypertensive (BP d 40/80) patients with type 2 diabetes in 
London, and used BP rather than HbA1, as the primary outcome. 
Results: Denver et al. report that the average systolic BP at 6 months in the 
intervention (NLC) group was significantly lower at 141.1 ± 19.3 mmHg, vs. 
151.1 ± 21.9 mmHg in the CPC, p=0.002. Patients in the NLC were also more 
likely to reach the systolic BP target of <140 mmHg (38% NLC vs. 12% CPC), 
and the diastolic target of <80 mmHg (50% NLC vs. 36% CPC), and lowered 
CHD and stroke risk scores. None of the secondary physiological outcomes noted 
above were significantly different between groups, including HbA1,. After 
analyzing their results statistically, including variables such as BMI and exercise 
level, the authors conclude that the NLC setting improves BP control. 
Assessment of validity: The NLC intervention ran for 6 months, with the 
intervention group attending monthly visits with the nurse during the first 3 
months and visits every 6 weeks during the second 3-month period. The authors 
have not reported any information about the frequency or number of visits the 
control "conventional primary care" (CPC) group attended. From their report, the 
CPC group apparently received no further intervention from the study after an 
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initial visit at which nurses obtained baseline measurements (BP; HbA1,; semm 
total cholesterol, semm high density lipoprotein (HDL) and semm total 
triglyceride concentrations; urinary albumin excretion rate, semm creatinine level, 
BMI), and reported the BP results to CPC providers with targets and guidelines 
via a letter. From the study report, I cannot say what, if any, follow up CPC 
patients had. 
There is a significant potential confounder in the result as presented, 
however. The NLC group visited the nurse-led study clinic 5 times over the 6-
month course of the study. Even if the control group enjoyed a high standard of 
diabetes care, they are unlikely to have made more than one or two visits to a 
clinic in that time. The NLC may provide some important aspect of care that CPC 
does not, but from this study we may reasonably conclude only that frequent 
follow up can improve blood pressure control. 
Denver et al. suffers from potential selection bias. Investigators referred 
their patients to the study "randomly" based on uncertain criteria, and the patients 
entered each arm on an alternating basis. The scheme is designed to reduce l 
referral bias, but does not meet an adequate standard for true randomization, 
despite the lack of statistical differences in reported baseline characteristics. It 
also cannot eliminate referral biases; for example, physicians may selectively 
refer more adherent patients, or those with more severe disease. As described for 
the previous study, if the intervention is more effective for the types of patients 
referred than for the general population then the effect sizes will be 
inappropriately altered. 
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There are also significant limitations on the external validity of this study. 
The NLC intervention is time-intensive for both patients and the nurses who staff 
the NLC, and may not be feasible in settings where time is limited. In addition, if 
the significant factor in the NLC intervention is frequency of follow up, there may 
be little or no benefit to populations whose follow up is already intensive, in 
whatever setting they receive their diabetes care. 
STRUCTURED DIABETES CARE 
Smith et al. (2004)- RCT of multifaceted, structured care intervention for type 2 
diabetes in private outpatient general practices (GP) clinics in north Dublin, 
Ireland.Z0 50 GP physicians recruited from a database of interested physicians 
were randomized, by an outside researcher using a random number table, to 
continue with usual care (the control) or to provide the intervention. GPs in both 
arms of this study were more likely to practice alone, and less likely to have a 
practice nurse, than Irish national averages. 
The structured care intervention was complex, and included: 6 weeks 
formal instruction for physicians and nurses beforehand; use of a community-
based diabetes nurse specialist (DNS), creation oflocal guidelines for care shared 
among participating practices; annual review of each patient's case by a specialist 
team of physicians and nurses; review of each patient's case every 3 months by 
the GP and nurse, and the introduction of structured record cards for each patient 
to facilitate primary-secondary care communication. The study continued for 18 
months, with researchers interviewing GPs at 12 months to assess progress and 
get feedback. 
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Included patients had to be 18 years or older, with type 2 diabetes 
diagnosed for at least one year prior to the study. Based on power calculations 
designed to detect a 0.9% absolute HbA1, change, the researchers recruited 183 
patients to the study from 30 practices representing all 50 GPs. 170 (92.9%) of 
these patients completed the study. 
The major outcome on which investigators based the power calculation 
was serum HbA1, at 18 months. Other biophysical outcomes were BP, total 
cholesterol, and BMI. Psychosocial measures included well-being, satisfaction, 
and smoking. Numerous process interventions also were assessed by patient and 
GP report, and by hospital records 
Results: No biophysical parameters were significantly different between groups 
at 18 months, and mean HbA1, did not fall over time longitudinally within either I 
group. Some process measures improved. The process measures that occurred in 
proportionally more intervention group patients were: recorded BP check in past 6 
months (intervention= 78%, control61 %; p = 0.046), documented smoking 
status (82% vs. 66% p = 0.024)), and tests for retinopathy (60% vs. 32%, 
p=0.024), microalbuminuria (45% vs. 11%, p = 0.004) and serum creatinine (46% 
vs. 9%, p = 0.001). 
Assessment of Validity: Overall internal validity for this study was fair. The GP 
physicians are a highly selected group who voluntarily attended educational 
meetings and were recruited to the study based on that involvement. Such a 
motivated cohort is likely already to be providing high-quality diabetes care, 
leaving less room for improvement. Baseline mean HbA1c values in both 
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intervention and control groups were under 7%. The authors selected the sample 
size to detect a 10% chm1ge in HbA1,, meaning that the mean value would have to 
fall to close to 6% to produce a difference statistically. The difficulty of 
achieving such exceptional control is likely a factor in the overall negative result 
for biophysical measures. 
Excellent baseline control cannot explain the negative results for BP or 
BMI, as these were both well above goals for the study cohort and also did not 
chm1ge longitudinally within groups over the study period. 
The random number table is not an adequate means of randomization, 
although the potential bias is probably somewhat reduced by having an outside 
person perform the randomization. The confounding that could result from 
inadequate randomization is a greater hazard if it produces a directional bias 
favoring the intervention, which is not a concern for m1y of the biophysical 
parameters that are most relevant to this review. 
The study is positive for some process measures, but these do not translate 
into clinical chm1ges. For some, the authors did not report clinical outcomes that 
correspond to the process changes, e.g. blindness, lower extremity amputation, or 
renal failure. The follow up period of 18 months is not likely long enough to 
capture significant changes in these outcomes even if the differences in process 
measures will eventually produce them. 
There is no methodological issue that cm1 explain the failure of the 
intervention to create differences in blood pressure. The follow up time should be 
adequate to see clinical and statistical differences between groups, and the authors 
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report statistically significant differences in process measures related to BP. 
Unlike HbA1c, BP was not well-controlled at baseline. Details ofthe 
implemented treatment guidelines show that physicians used a staged approach to 
gradually achieve target levels of biophysical outcomes. The authors provide no 
further details of how the GPs approached BP specifically, but they may not have 
been aggressive enough in monitoring and following up with treatment 
adjustments. GPs and patients both qualitatively GPs' limited time and financial 
resources as problems. Both indicated that GPs were unlikely to perform routine 
reviews or delve in-depth unless patients or nurses indicated a problem. BPs that 
are moderately high may not have elicited particular alarm, especially if they were 
consistent. 
Financial, temporal, and resource limitations are likely to be problematic 
in any setting to which this intervention is adapted. In Ireland, patients pay only 
for GP care and have free options to receive care in hospitals. In the US setting, 
where similar guaranteed care does not exist, such an intervention may be even 
more daunting to apply and maintain. Given that the authors show limited 
success by process outcomes, and none by biophysical outcomes, we cannot 
estimate whether similar interventions may work in a different setting. 
Studies of Processes of Care 
PSYCHOLOGICAL MONITORING 
Pouwer et al.- RCT which examined the effect of standardized psychological 
monitoring on psychological outcomes and on HbA 1c 26 , following a World 
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Health Organization (WHO) recommendation39 The intervention consisted of a 
single 15-minute computerized assessment of psychological well-being (W-BQ) 
at 6 months in addition to usual care, which was the control and consisted of 
appointments at the same Amsterdam hospital's diabetes clinic every 3-4 months. 
The control group was further divided into Cl and C2 groups. The Cl group and 
intervention groups each completed the W-BQ at baseline, while C2 were not 
asked to complete the baseline W-BQ. This technique was used to see if the 
baseline W-BQ itself could stimulate patient awareness of psychological issues 
and therefore confound the result. Patients in the Cl and C2 groups showed no 
differences in number of psychological referrals or in study outcomes, and were 
analyzed together for the purposes of the study. 
Results: Differences with small statistical and clinical significance in the global i 
well-being questionnaire, and its subtests assessing energy and negative well-
being, were noted at one year. Glycemic control measured by HbA1, showed no 
difference between groups. Likewise, mental health assessment by the Medjcal 
Outcomes Health Survey Short Form 36 (SF-36) and patient satisfaction with 
both the physician and the diabetes nurse, assessed by the Patient Evaluation of 
Diabetes Care (PEQD), showed no difference between groups. 
The Pouwer et al. study had a dropout rate of 12% after randomization, 
and although the authors provide the reasons why patients dropped out (moving 
away, death, time constraints), none of the known characteristics of these patients 
is reported or compared to those who completed the trial. Further, there is no 
indication of which patients dropped out of which group. More patients (32) 
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dropped out of the control group than the intervention group (23), but the reasons 
for this are not explained, raising the possibility of selection bias. 
Patients completed some of the study materials at horne, which may affect 
some feelings of well-being and skew the results. However, the size and direction 
of such an effect is not clear, and its effect on the result is uncertain. 
Pouwer et al. have shown a very small effect on the psychological 
instruments, which the investigators have called clinically significant based on a 
calculation of effect size with arbitrary cutoff values. The effect may be 
important for psychological well-being, but does not appear to affect the 
physiology of diabetes control. Even if this small effect exists in the Dutch 
population and is important psychologically, it is not clear how to generalize a 
psychological support intervention to populations with different social systems 
and healthcare structures, and varying extant levels of personal and professional 
psychological support. 
ADDITION OF CASE MANAGEMENT TO PRIMARY CARE 
Rothman eta!. (2005)- RCT of pharmacist-led disease management program 
added to primary care.22 285 patients were referred from a primary care clinic in 
North Carolina, of whom 217 participated. All patients received an initiall-hour 
pharmacist-led management session after which they were randomized to either 
the usual care control or to the intervention. The intervention was an intensive 
disease-management program, in which the pharmacist held intensive educational 
sessions, counseled patients, and managed medications according to clinical 
algorithms. Pharmacists were in contact with patients every 2-4 weeks, with more 
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frequent contact initiated if necessary. Pharmacists also dedicated clinic slots 
during which they could see patients, alone or in consultation with a physician. 
Results: The intervention group had a significant 2.5% decrease in HbA 1,, 
compared to a 1.6% decline in the control group at 12 months (difference between 
groups= 0.8%, p = 0.05). Systolic BP was 5 mmHg lower in the intervention 
group compared to the control (p = 0.02), and 91% oftbe intervention group took 
aspirin at 12 months, compared to 58% of the control (p < 0.0001). There was no 
difference in serum cholesterol between groups. The authors also report 
improvements in patient satisfaction and diabetes knowledge in the intervention 
group compared to the control 
Assessment of validity: Randomization scheme was performed with a random-
number generator, and the allocations were concealed in envelopes opened by the 
study coordinator when the assignment was made. Despite the apparent 
methodological soundness ofthe scheme, there were some differences between 
groups in baseline characteristics. The intervention group was slightly younger 
and had a higher percentage of African-American patients than the control. 
Although this does indicate that randomization may have been faulty, the authors 
report that they calculated results adjusted for these characteristics that were 
similar to those reported. 
Measurement of the major outcomes was objective and standardized, with 
BP measured using automated devices by nurses who were unaware of patients' 
group allocations. 
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Regarding external validity, the patient population was drawn from a 
clinic that served a spectrum of patients economically and racially. Similar 
patients, whose diabetes was out of control by HbA 1c. should benefit. The authors 
emphasize that the entire intervention occurs in the context of a general primary 
care clinic, rather than a specialty diabetes clinic. However, the intervention 
requires intensive commitments from the pharmacist practitioners, and patients 
willing to have those providers visit them at home or work. In settings where 
such pharmacists are not available or cannot be dedicated to patient care, the 
intervention may not be possible to implement. 
Taylor et at. (2003)- RCT of nurse case manager added to usual primary care for 
patients with one or more comorbidities (hypertension [HTN], dyslipidemia, or 
coronary vascular disease [CVD]).24 The investigators identified patients using 
ICD-9 codes in a database at the Kaiser Permanente Medical Center in Santa 
Clara, CA. Investigators excluded patients who were non-English speaking, were 
unwilling to participate, had a primary diagnosis of congestive heart failure, were 
<18 years old, pregnant, or enrolled in DM management clinic; or lived too far 
away. 169 patients were eligible and willing to participate, and investigators 
randomized them by unspecified means to a usual care control group or to the 
intervention. 
Control patients received written pamphlets about diabetes and a short 
instruction sheet encouraging them to follow up with their physicians and to 
attend diabetes education classes. They were told that in one year they could 
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receive a workbook and meet one-on-one or attend a class with a nurse case 
manager. Intervention patients first met for 90 minutes with the nurse case 
manager to have an initial assessment and to set self-management goals. This 
visit included a foot check and BP and pulse measurements by the nurse. At the 
initial visit, the nurse case manager encouraged intervention patients to attend a 1-
2 hour weekly group class that included both instruction and discussion about 
problem-solving. The nurse case manager also followed up with several 15-
minute telephone calls to review goals, check patient status, and assess the need 
for any medication changes. Nurses followed treatment algorithms and made 
medication change recommendations to intervention patients' physicians when 
indicated. 
Major physiologic outcomes included HbA1,, lipid profile, plasma I 
glucose, urine microalbumin, and BP, all drawn by the nurse. Process measures 
included foot, eye, and dental checks, flu shot, and Pneumovax shot. To measure 
psychosocial dimension the investigators used the Short Forrn-36 and Duke 
Activity Status Index for quality of life, and the Beck Depression Inventory (BDI) 
to assess depression. 
Results: The authors reported physiologic parameters both as mean change from 
baseline and as percentage of patients in each group who met goal cutoffs at one 
year. The only parameters for which there was a significant difference in mean 
change between groups were %HbA 1, (intervention~ -1.14, control~ -0.35; p ~ 
0.01), total cholesterol (intervention~ -20.6, control~ -11.5; p ~ 0.01), and LDL 
cholesterol (intervention~ -19.4, control~ -6.5; p ~ 0.02). The only parameter 
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for which a significantly greater number of intervention patients met the goal after 
one year was HbA1,, with the goal value being :S7.5% for this study (42.6% 
intervention patients, 24.6% control; p < 0.03). None ofthe psychosocial 
parameters was significantly different between groups. 
Assessment of Validity: Of 341 eligible patients whom the investigators could 
reach, only 169 (49.6%) participated, creating a significant volunteer bias in the 
study sample. However, this bias should be nondifferential and would tend to 
drive the result to the null, which was not a flaw in this positive study. 
The measurements the investigators used for the physiological parameters 
that are the focus of this review were sound methodologically and valid for 
assessment of diabetes disease state. The study was too short and the sample too 
small to assess the significant outcome of mortality, although such measurement 
in this poorly controlled sample with comorbidities would be feasible in a larger 
study over 5-l 0 years. 
The randomization scheme was not specified, but all reported baseline 
parameters were similar between groups. The investigators have not reported any 
confounding factors that could account for the positive result of the study. 
The population in this study was loosely representative of the general 
population by race, evenly distributed by sex, and included patients of varied 
educational levels. We could reasonable expect this result to be repeated in other 
urban populations. The major limitation on external validity is the availability of 
qualified nurse case managers. The authors acknowledge that the case manager is 
highly trained and experienced, and such people are likely to be both rare and 
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expens1ve. There may also be social barriers to an intervention in which a nurse 
frequently calls to ask the patient extensive questions about medications and 
physical and mental status. 
New eta/. (2003)- RCT of nurse-led intervention in addition to primary care for 
British patients with diabetes and either hyperlipidemia or hypertension, or both?5 
Investigators used an electronic diabetes register in the Salford, U.K. region to 
identify 1,407 patients with a diagnosis of diabetes and total cholesterol> 5.0 
mmol/L (193mg/dL) or blood pressure (BP) > 140/80 mmHg. The investigators 
randomized patients, using an external randomization center, to either a usual care 
control group or to separate nurse-led interventions for hypertension or 
hyperlipidemia management. Randomization to each clinic was independent, and 
eligible patients could be randomized to one clinic and serve as a control for the 
other. The report does not state whether any patient could be randomized to both 
interventions. 
For each disease state, the intervention began with a 45 minute individual 
session with the nurse, at which the nurse discussed the reason for the visit, 
treatment targets, and the reasons for targets. The nurse took a detailed disease 
history and assessed the relevant physiologic parameter by either 
sphygmomanometer or blood draw. Next the nurses saw each patient at 4-6 week 
intervals for 30-45 minute appointments to reinforce teaching and goals, until 
goals were achieved (cholesterol < 5 mmol/L or BP < 140/80). Patients were then 
assessed at one year to determine what proportion had maintained their treatment 
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goals. Invited patients who did not attend were included in the analysis and 
counted as patients who had failed to achieve targets. The lipid clinic and 
hypertension clinic were each run by separate nurses. 
Results: The authors report major outcomes as an odds ratio (OR) in the format: 
Odds( intervention patients achieved goal I control patients achieved goal) 
They also provide absolute percentages of patients who achieved targets. In both 
clinics combined, 37.2% of intervention patients achieved treatment goal, which 
was significantly higher than the 30.7% of controls who met targets (OR~ 1.37 
[95% CI 1.11 - 1.69]). The hyperlipidemia clinic alone produced a statistically 
significant difference, with 53.3% of intervention and 40.3% of control patients 
meeting goals (OR~ 1.69 [95% CI 1.25-2.29]). The hypertension intervention 
analyzed alone was less successful and did not produce a statistically significant i 
difference between groups. 
The investigators report a significant difference in mortality between 
controls and all intervention subjects, with 3.2% mortality among intervention 
patients and 5.7% among controls (OR 0.55 [95% CI 0.32-0.92]). 
Assessment of Validity: This study was methodologically sound and rated 
"Good" for internal validity. Unlike many other studies ofthis type, volunteer 
bias was removed by including all invited patients, although overall 21% of 
patients did not attend. This approach should more accurately assess 
effectiveness of the intervention and improve its external validity. Analyzing 
dropouts with the cohort will drive the result toward the null. This effect is 
possibly the reason for the hypertension clinic's failure to produce significant 
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differences between groups, as 41% of invited patients failed to attend, compared 
to 16% for the hyperlipidemia clinic. The authors acknowledge this difference 
and its potential effect. 
Randomization by an external service and masking of all providers except 
the nurse leaders should reduce confounders and measurement bias. In addition, 
the outcome measures used were standardized and objective. The protocol for 
BP, the more subjective measure, was explicit and standard. 
This intervention had statistically significant effects that are also likely to 
be clinically significant, as reflected in the surprising difference in mortality at 
one year. The content of the intervention was moderately intensive, but could be 
exported to other settings with different social and cultural contexts, particularly if 
the nurse leaders are from the target community. A threat to external validity is 
the availability of resources, including trained nurse leaders and adequate time 
and money to allow them to execute the intervention. 
California Medi-Cal Study Group (2004)- RCT of nurse and dietician case 
management for low-income ethnic minority patients in California with type 2 
diabetes for at least one year7 Study investigators randomized 362 eligible 
patients from three clinical sites in southern California to either usual care or to 
the case management intervention. Of these, 45 (17 intervention, 28 control) had 
no further HbA1c measurement and were excluded from the analysis. The 
intervention included structured education from certified diabetes educators and 
intensive case management by registered nurses and registered dieticians. Case 
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management included appointment scheduling, helping with transportation issues, 
medication monitoring with changes recommended using treatment algorithms in 
collaboration with the primary care provider. All intervention patients received 
the same glucose meter and instructions on how to use it. 
All study participants in both groups had HbA1, measurements taken 
every six months, and the mean duration of follow up was 25 months. 
Results: The major outcome was HbA1, change over time in each group. The 
study investigators included all patients in the analysis who had at least one 
baseline and one follow up HbA1, measured. Because the decline in glycosylated 
hemoglobin is initially rapid and then slows, mixed effects statistical modeling 
was used to adjust for this effect among those lost to follow up after at least two 
measurements. At every time point except baseline, HbA1, was significantly 
lower in the intervention group, with progressively greater differences at later 
times. At 36 months, the longest follow up, the difference was 0.80% 
(intervention= 7.66 ± 0.17, contro18.53 ± 0.20; p < 0.01). The mean baseline 
HbA 1, was 9.54 in the intervention group and 9.66 in the control (p = 0.51). 
Assessment of Validity: This study mostly avoids volunteer bias by including all 
eligible patients as enrollees and analyzing all patients with any follow up value. 
The investigators were somewhat selective in choosing patients with inadequate 
glycemic control but no complications. However, this is a reasonable selection, 
both to get a clear picture of the intervention effect, and because many such 
patients exist who could reap significant benefits by improving their control 
before complications arise. 
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Dropouts are a serious problem for studies ofHbA1, because declining 
values are not linear initially, which can create overly positive results if linear 
modeling is used to estimate intervention effects. This group accounted for the 
decline statistically, which improves the confidence we can place in their result. 
Although masking ofthe primary provider is not specifically addressed, 
the intervention occurred in their offices, and sufficient masking was unlikely. 
However, most providers were taking care of both control and intervention 
patients, and we should presume that they were providing their best care to both 
sets of patients. The study collected no subjective measurements, so the 
unmasked primary care providers are unlikely to be a source of bias. 
Case management as a strategy is inherently intensive, and like other 
studies of this type the external application of this intervention is potentially quite 
limited by the financial and temporal availability of qualified, dedicated 
managers. However, in settings that have access to such people, this broad-based, 
algorithm- and guideline-driven intervention should be applicable. 
Sone et at. (2002)- The Japan Diabetes Complications Study (JCDS), a 
multicenter RCT of intensive lifestyle modification and management added to 
primary care in J apan.23 The investigators enrolled 2205 patients from 59 
diabetes specialty centers in Japan to be randomized, by undescribed means, to L 
either usual care (the control) or the lifestyle intervention. All enrolled patients 
had previously been diagnosed with type 2 diabetes with HbA1, >6.5%, and had 
albumin excretion< 150mg/g creatinine and serum creatinine levels< 1.3 mg/dL. 
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This paper is an interim report, and for certain future endpoint analyses patient 
with existing micro-and macrovascular disease histories will be excluded. 
However, for the 3-year HbA1, reported as the major outcome here the 
researchers have not excluded these patients. 
Patients receiving the intervention in JCDS received 15 minutes of 
telephone counseling about diet, exercise, and treatment adherence at least 
biweekly from a nurse educator. Educators encouraged additional counseling 
sessions as patient need dictated. At each outpatient visit, physicians evaluated 
actual changes in diet and behavior. The interval between visits is not specified in 
this report. Intervention subjects also received printed educational materials, a 
pedometer, and a diary to record the progress oflaboratory and physical exam 
data. Study personnel identified patients with poor control (HbA1c > 8.0%, BMI i 
> 22 kg/m2, serum total cholesterol> 220 mg/dL, or serum triglycerides > 150 
mg/dL) and sent them additional educational materials, as well as contacting their 
physicians to make therapeutic regimen changes to address the problems. 
Results: At 3 years, investigators report a small but statistically significant 
difference in %HbA1c between the intervention and control groups 
(intervention= 7.53 ± 1.2, control= 7.70 ± 1.2; p = 0.0004). No other 
parameters showed significant differences between groups. 
Assessment of Validity: The report of this large, multicenter randomized 
L 
controlled trial does not provide very detailed methodological information. The 
methods that are reported are promising. For a large study of an intensive, long 
term intervention, the dropout rate is below 12% and nondifferential. However, 
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the authors provide little information about how they selected and randomized the 
cohort. Without knowing characteristics of the cohort, we cannot adequately 
assess the effects of possible selection biases. Similarly, many details of the 
treatment regimen are missing. The authors do not tell us whether intervention 
patients have specified follow up intervals, or what those intervals are. 
The clinical significance of the 0.2% 3-year difference in HbA1, is 
uncertain. No study has shown a long-term clinical benefit for a change that 
small. The authors point out that control in both groups is already relatively tight, 
with both mean HbA~c values below 8.0% and longitudinal improvements in other 
parameters, which failed to produce a between-groups difference. This is true, 
but may simply indicate that intensive lifestyle management is unnecessary and 
adds little value in the Japanese outpatient context. The authors explain that they I 
designed the intervention to be relatively unobtmsive and sensitive to patients' 
aversion to highly intensive regimens. The approach may therefore have been 
less aggressive than necessary to create change in a population with fairly good 
baseline control. 
Because of the uncertain clinical advantage shown by the JDCS, other 
systems are unlikely to try to apply this intervention. An advantage of the JDCS 
approach is that the designers attempted to make it as acceptable as possible to the 
target Japanese participants. However, what is acceptable to external populations 
may be different than what is acceptable to the patients studied in Japan. Any 
intensive management intervention will have to be carefully tailored to the target 
population. 
44 
COUNSELING FOR PHYSICAL ACTIVITY 
DiLoreto et al. (2003)- RCT examining the effect of additional, directed 
counseling on patients' physical activity levels, HbA1,, and BMI.27 340 
consecutive patients over 2 months from an Italian Outpatient Diabetes Clinic 
were randomized by undescribed means to intervention or control groups. The 
usual care group received an initial 30 minute visit with general counseling on 
diet and exercise by a physician, follow up visits every 3 months, a diary to record 
physical activity, and general advice and brochures at visits. In addition to this 
regimen, the intervention group got an addition 30 minutes of directed physician 
counseling about physical exercise at the initial visit. Intervention patients also 
received a telephone call at one month from the same physician who counseled 
them at the initial visit to determine whether the plan for physical activity was 
being followed. The call could be extended to include 15 minutes of 
reinforcement counseling if the patient described problems. The study continued 
for 2 years. 
Results: At 2 years, the intervention group had significantly lower HbA1, than the 
control (intervention= 7.0%, control= 7.6%; p<O.OOl). The control HbA1, value 
was unchanged from the beginning of the study, while the intervention group 
value decreased from 7.7% at baseline (p<O.OOl). 
BMI in the intervention group decreased significantly from baseline (29.3 
at baseline, 28.9 at 2 years; p<O.Ol) while the control group BMI increased 
significantly from 29.8 at baseline to 30.4 at 2 years (p<O.Ol). 
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Self-reported physical activity, measured via diaries, was statistically the 
same at baseline, but was seven times greater in the intervention group at 2 years. 
Further, 69% of the intervention group, vs. 18% of the control group, achieved the 
target energy expenditure of>lO METs x h!week. 
Assessment of validity: DiLoreto et al. exhibits potential selection biases in that 
the sample is a convenience sample of consecutive patients in the clinic, which 
may not be representative of the clinic population. This issue may be partly 
remedied by the large sample and relatively long enrollment period, and by 
randomizing every patient. However, even over two months this technique will 
skew the sample toward those patients who follow up regularly, and who may be ! 
The randomization scheme is not described, so we cannot assess its I more adherent in other aspects of care. 
adequacy. Although all reported baseline characteristics, including BMI and 
HbA1,, were similar between groups, this cannot ensure that they are 
appropriately randomized. 
Because ofthe type of intervention, allocation concealment is impossible 
for providers and patients. The providers in DiLoreto et al. apparently include the 
authors, perhaps exclusively, although this is not explicitly stated. This could 
present a measurement bias if the outcomes were subject to interpretation, but the 
major outcomes BMI and HbA1, are largely resistant to this problem. 
The highly subjective self-report of physical activity is subject to 
measurement bias, including patient recall bias, but the authors show correlations 
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between reported physical activity and the more objective physiological 
measurements. 
This study has several potential threats to internal validity, but none of 
these potential biases is adequate to explain the significant lowering ofBMI and 
HbA1, the investigators report. Among the selected patients the intervention was 
effective. 
External validity for this study is uncertain. The patients were all Italians 
from one diabetes clinic, and potentially more adherent than the general 
population because of the sequential selection process. In addition, the 
intervention requires a large time investment from both patients and physicians, 
beginning with a doubling of the initial appointment time. In settings where time 
is scarce, e.g. many American primary care clinics, using this extra time may not 
be feasible. 
GROUP CHRONIC CARE VISITS 
Wagner et al, (2001)- RCT of group diabetes chronic care clinics added to usual 
care
40 Within a large HMO in the Seattle area, the investigators randomized 
practices to either the chronic care clinic intervention (n=14) or usual care (n=21). 
The intervention involved inviting patients to come as a group to clinic visits 
every 3-6 months. At the visits, patients would have a usual one-on-one visit with 
a physician, pharmacist, and nurse. Intervention patients also participated in a 1-
hour group education and support session. The study period lasted for 24 months. 
The investigators measured processes of care and patient satisfaction via a 
self-report questionnaire mailed to patients. Those who did not reply by mail 
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received a follow up telephone call. Investigators also used the mail/telephone 
questionnaire to assess health status, using 3 subscales of the Medical Outcomes 
Study short form 36 (SF-36) (general health, physical function, and physical role 
limitation); to administer the Center for Epidemiologic Studies Depression scale 
(CES-D); and to assess bed and restricted-activity days. Physiologic outcomes 
were obtained from administrative databases. 
Results: There was no difference between groups in either of the major 
physiological outcomes measured (total cholesterol and HbA1,) at 24 months. 
Some process measures at 24 months were significantly better in the intervention 
group, especially self-reported frequency of prevention procedures. %patients 
with 1 or more bed disability days was lower (intervention~ 31.5%, control 
39.4%; p~0.02) and the general health subscale of the SF-36 was significantly 
higher (intervention~ 46.8, control~ 44.0; p ~ 0.03) in the intervention group at 
24 weeks. 
Assessment of validity: There were significant problems with the process of 
selection. Each clinic in the HMO (containing 5-20 practices) was permitted to 
choose whether to participate in this diabetes study, or in a separate study of frail 
elders. The means by which the investigators randomized the practices was not 
described, but produced an unbalanced 3:2 ratio of control to intervention 
practices, when this was not a stated goal. This imbalance increased when 3 
intervention practices were eliminated altogether by administrative changes in the 
HMO and dropped out of the study. 
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Within each practice, a maximum of 36 patients participated, selected 
randomly by an undescribed process. Unmasked physicians were responsible for 
identifying and excluding ineligible patients, creating referral bias. Among 
invited patients, 70711001 (70.7%) completed entry forms, but only 65% of these 
patients ever attended a single clinic session (46% of eligible, invited patients). 
The patients who did not attend group sessions are crossovers, who will tend to 
drive the outcome toward the null. 
The physiological outcomes were objectively measured and standardized, 
and were negative. Glycemic control at baseline was fair in both groups 
(intervention HbA1, = 7.5, control HbA1, = 7.4), which may have made it more 
difficult to improve. The authors present data that shows patients who attended 
more clinics had significantly better physiologic outcomes, but this analysis i 
represents data mining as it was not laid out as part of the investigation scheme 
beforehand. It is also subject to significant confounders, e.g. patients with better 
control may be more able to travel to attend the clinic, or may be more generally 
adherent. 
Process outcomes, particularly for preventative procedures, were better in 
the intervention group. However, measurement was by self-report, and rather 
than counting events a subjective 5-point scale was used, with 1 =never have 
preventive procedures and 5 =have at every visit. The authors do not provide 
descriptors for values 2,3,4. When the authors report %patients who had specific 
tests (medication review, annual eye exam, annual foot exam, annual 
microalbumin), only microalbumin differed significantly between groups. 
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External validity is difficult to assess because there is no description of the 
actual group of participating patients. The HMO as a whole may represent the 
Seattle population, which may be a fair estimate of other urban American 
populations. However, through the many levels of selection, many of which are 
obscured in the report, we cannot say to whom these results would apply. This 
essentially negative study cannot tell us that the group chronic care model is 
effective for any particular population of patients, but it should not be used to rule 
such an intervention out. 
COMMUNITY-BASED NUTRITION AND EXERCISE GROUPS 
Goldhaber-Fiebert et a/.(2003)- RCT of community-based group nutrition and 
exercise program for patients with type 2 diabetes in rural Costa Rica28 
Investigators recruited 75 patients from social work contacts, a list of hospital 
patients, and community advertisements. Patients were randomized by unknown 
means to a usual care control or to the intervention. Both groups received a 
single, standard lecture on type 2 diabetes before randomization. The intervention 
consisted of 11 weekly 90-minute nutrition classes, taught by one of three 
nutritionists. Additionally, intervention patients who did not have 
contraindications (insulin use, open foot ulcer or active coronary artery disease) 
were invited to join walking groups. 20 I 40 intervention patients met criteria to 
join the groups, which walked 60 minutes, 3 times per week for 12 weeks. Nine 
declined because of arthritis or low back pain. 
Measured outcomes included height, weight, blood pressure (BP), 
glycosylated hemoglobin (GHb), fasting plasma glucose (FPG), and plasma lipids 
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(total cholesterol, HDL cholesterol, and triglycerides). Both the primary 
physicians and laboratory technicians were masked to group allocation. Primary 
physicians were aware that subjects were enrolled and asked to refrain from 
nonessential medication or dosage changes for the 12-week trial period. The 
investigators asked to be informed of all medication changes. 
Results: The investigators reported all outcomes in terms of the mean change in 
the variable for each group at 12 weeks. Absolute values are only reported at 
baseline, and there is no indication whether the mean values were statistically 
different between groups for any parameter. The intervention group decreased 
HbA1, by a mean± SD of 1.8 ± 2.3%, while the control group experienced a 
mean increase of0.4 ± 2.3% (p = 0.028 for difference between groups). Changes 
in weight, BMI, and FPG were also significantly larger in the intervention group. 
Changes in lipid and blood pressure values were not statistically different between 
groups. 
Assessment of Validity: The method of recruitment is vulnerable to both 
volunteer and referral biases. People who were already connected to the health 
system would be heavily favored by hospital lists and social work contacts. One 
indicator that the sample is not representative of the population is that 59 I 70 
(84.3%) of the participants were women. The dropout rate was moderate (14 I 75 
= 18.7%) and evenly matched between groups. The authors report that dropouts 
were similar to other subjects at baseline, but no further data is presented. 
The selected parameters and their mode of collection and measurement 
were all sound, as was implementation of masking when it was feasible. The 
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investigators attempted to control for medications and number of provider visits. 
The authors have presented data only on the change in outcome parameters. This 
information is important, but doesn't give us a complete picture of the 
effectiveness of the intervention. For instance, the mean GHb change was 
negative in the intervention group and positive in the control, but each group had 
standard deviations larger than the mean change, meaning that there could be 
positive and negative changes in each group. 
The results of this study may be applicable to outside populations, but 
perhaps not directly. Cultural adjustments in the nutritional teaching would 
probably be necessary. This population was mainly rural Costa Rican women 
with moderate to poor glycemic control (baseline GHb 8.6%). For men, non-
Hispanic populations, urban populations or populations with markedly worse 
baseline control, we cannot draw conclusions about the applicability of this study. 
The ability to walk freely in groups may be restricted, especially in areas where 
street design is almost exclusively automobile-centered, as in many American 
cities and towns. The time this intervention requires from patients is somewhat 
intensive, and may not be realistic for those who have many other demands on 
their time. Given these limitations, this intervention should be relatively cheap to 
implement and may be effective for some external populations. 
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Studies of Educational Interventions 
COMPREHENSIVE EDUCATION PROGRAMS 
Polonsky et a/.(2003) RCT testing the Diabetes Outpatient Intensive Treatment 
(DOlT) education program against a control arm that received usual care and 
mailings about diabetes (termed EDUPOST). 30 Patients who agreed to 
participate were randomized, by unreported means, to DOlT or EDUPOST arms. 
The study was performed at a large military hospital in Hawaii. The DOlT 
intervention was limited to 12 patients at a time and was highly intensive, 
involving 3.5 days straight of patient time. Subjects received a wide spectrum of 
education regarding risk reduction, diet, exercise, glucose measurement, and 
psychosocial issues. Stafftime commitments were also intensive, with the entire 
staff meeting on day 2 to plan the approach they would take with each patient. 
Following the 3.5 day "experience", case managers contacted the patients by 
phone at least quarterly, and met with one another weekly to discuss patient 
progress over the 6 month follow up. 
Results: The main outcome measure of the DOlT study was HbA1, at 6 months, 
with DOIT patients having A 1, measurements almost l% lower than EDUPOST 
patients (7.9% vs. 8.7%, p<O.OS). Other measures of self-care were consistently 
better in the DOIT group. 
L 
Assessment of validity: A high dropout rate, particularly from those randomized 
to the EDUPOST group (EDUPOST = 29/98, DOIT = 9/97), creates a selection 
bias. Even among the analyzed patients, both interventions showed a reduction in 
HbA1, from initially similar average values above 10%. lfEDUPOST patients 
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lost to follow up were improving, their large numbers may have been enough to 
affect the outcome of the trial. Characteristics of the dropouts were not given for 
either group, making it impossible to tell whether such differential loss to follow 
up occurred. 
Finally, this study has a threat to external validity in the significant 
resources the DOlT intervention demands from both providers and patients. In 
settings where patients cannot spend several full days receiving the intervention, 
or in which providers are not available to give such intensive instruction, DOlT 
would not be practical. 
PATIENT SELF-MANAGEMENT INTERVENTIONS 
Rachmani et at. (2002)- randomized controlled trial of 141 Israeli patients in I which they provided a single 90-minute teaching session directed to encourage 
patient participation in their own care31 . 
The primary aim of the study was to assess vascular complications, using 
the estimated glomerular filtration rate ( e-GFR) as the primary outcome measure. 
Other measured parameters included albumin/creatinine ratio, BMI, BP, LDL 
cholesterol (LDL-C), retinopathy, and HbA1,. The investigators used random 
numbers to allocate patients to each arm of the study although it's not clear from 
reading multiple studies on the cohort whether a computerized or paper table was 
used. Both groups were well-matched in baseline characteristics. 
The authors dubbed the groups standard consultation (SC), the control, 
and patient participation program (PP), the intervention. All patients had one 
initial visit for assessment. At the second visit, the SC group had a 30 min visit 
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for an explanation of their medical issues, after which the investigators sent a 
letter to the primary physician. PP patients had a 90 minute teaching session 
during which they were charged with responsibility for meeting certain BP, LDL-
C, and HbA1, goals, which were written down. They were instructed to keep 
careful track ofBP at home using standard electronic cuffs, and to request 
therapeutic adjustments of their primary care physicians if they could not meet 
goals. The consultant/investigator offered patients the opportunity to initiate 
telephone contact or follow up visit if they needed further advice. The consultants 
gave letters directly to the PP patients and never contacted their physicians 
directly. After the initial two visits, all patients followed up with the study 
investigators annually for 4 years, in addition to their regular contact with their 
primary physicians. i 
Results: The authors note as an intermediate outcome that the PP group initiated 
an average of about I extra visit per year to their primary physicians, most often 
because of a failure to reach treatment .goals. PP patients were also much more 
likely to take renin-angiotensin system blockers (PP~lOO%, SC~54%) and lipid-
lowering medications (PP~lOO%, SC~74%) than those in the SC group. 
At the end of the study, e-GFR was significantly higher in the PP group 
(PP ~ 98±8; SC ~91± 9). Both systolic and diastolic BP were lower in the PP 
group by 6 mmHg (SBP, PP~J42 vs. SC~148) and 4 mmHg (DBP, PP~ 84 vs. 
SC~88). HbA1, was lower by 0.7% (PP~8.2%, SC~8.9%). The SC group had a 
cumulative retinopathy prevalence of 42%, compared to 26% in the PP group. 
LDL levels were lower in the PP group (PP~114 vs. SC~l24), but this difference 
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is of uncertain clinical significance. Finally, the albumin!Cr ratio was lower in 
the PP group (PP~44mg/g, SC~69 mg/g). 
The investigators measured all the clinical outcomes in this study on an 
annual basis, and except for e-GFR in the first year, all parameters trended in a 
way that favored the intervention (PP) arm. 
Assessment of validity: This study was methodologically quite sound, with an 
acceptable randomization scheme, and objective, measurable outcomes that 
minimize measurement bias. All of the reported outcomes are also likely to be 
important to diabetic patients and their physicians in a clinical setting. I judged 
this study to have "Good" internal validity. 
Rachmani eta/. (2005) published new data on the same cohort of 141 adults with 
diabetes, hypertension, and hyperlipidemia. The primary outcome for the more 
recent report was a combined cardiovascular disease index at 8 years follow up32, 
which tallied events including CVD mortality, non-fatal myocardial infarction 
(MI), non-fatal stroke, coronary artery bypass surgery (CABG), coronary 
angioplasty (PCI), amputation, and vascular surgery to give a total. The authors 
admit that they derived this outcome post hoc for the existing cohort from the 
2002 study. 
Results: The 2005 study shows that the PP intervention group suffered fewer of 
the events included in the index as described above (PP~52, SC~SO; p<O.OOI). 
Breaking down the index, the PP group showed statistically significant lower 
relative risks for any stroke (RR~0.47, p~0.008); coronary vascular interventions 
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[CABG + PCI] (RR~0.7, p~0.04); and all non-fatal CV events (RR~0.65, 
p~O.OOl). The PP group also continued to have less annual decline in e-GFR (PP 
~ 3.0 ± 1.8mL!min/1.73m2, SC ~ 4.6 ± 2.1 mL!min/1.73m2; p~O.Ol). 
Assessment of validity: The 2005 study is potentially limited by the post hoc 
creation of its primary endpoint. The authors also have not explained the means 
by which they obtained information about CVD events, some of which are subject 
to more interpretation than the objective measures reported in the 2002 paper. 
Misattribution of some outcomes is potentially a serious problem for these data, 
but we have no reason to assume that a reporting bias would be differential, and if 
the bias is not greater in one group than another, it would drive the result toward 
the null (no effect). Indeed, the measure subject to the most interpretation ("all 
MI") is the only one aside from mortality that fails to reach statistical significance 
between the groups. Although we cannot ascribe this result to a null-directed 
bias, we must consider the possibility that such a bias plays a role. For some of 
the measures such a bias is unlikely, especially PCI and CABG, although how the 
investigators determined whether a subject underwent either is never explicitly 
stated. 
Another weakness of the study is that the investigators powered their 
original study to find a difference in e-GFR, and the sample size is insufficient to 
find differences in CVD mortality between groups. Although we may assume 
that reducing CVD events is likely to reduce CVD-related mortality for a given 
time point, we cannot prove that assertion with this study. 
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These studies are likely to be externally valid for some populations. 
Rachmani et al. set some important parameters to maximize success. Their 
population contained no smokers, no one with diabetes of greater than I 0 years 
duration at the beginning of the study, and no patients who had suffered acute 
coronary events or who had significant comorbidities. They were also all 
volunteers, an important point because for this brief intervention to have an effect 
lasting four years probably requires empowered patients who will take an active 
role based on a brief educational intervention. Finally, because this study took 
place in Israel, it is not clear exactly how the results might translate in a setting 
with a less culturally homogenous and cohesive base of patients and physicians. 
Norris et at. (2002)- meta-analysis of patient self-management education 
literature from 1980 to 199941 Using the MEDLINE, CINAHL, and ERIC 
databases, the investigators searched the literature for studies that matched the 
MESH headings "diabetes mellitus" and "health education". They also hand-
searched the journals Diabetes Care, The Diabetes Educator, Diabetes Research 
and Clinical Practice, Diabetologia, and Diabetic Medicine. Included studies had 
to be RCTs, in English, using glycated hemoglobin (GHb ), HbA1, or HbA1, as a 
major outcome. The investigators stratified the studies by duration of follow up 
into immediate follow up, follow up between one and three months, and follow up 
at greater than four months. 
Results: The point estimates for each follow up period show reductions in GHb 
after self-management education. Immediate follow up had the largest drop, 
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-0.76 [95% CI -1.18 to -0.34], with 1-3 month follow up having a nonsignificant 
drop of -0.26 [95%CI -0.73 to 0.21] and ~4 month follow up having a significant 
decrease of -0.26 [95% CI -0.48 to -0.05]. 
The authors also looked at other factors in the reviewed studies, and 
determine that duration of patient contact is also important to maintaining 
decreases in GHb. 
Assessment of validity: The methodology used by Nonis et al. is strong. They 
have clearly explained the important elements of their selection process and of the 
techniques they used for their meta-analysis. They described the reasons for 
search limits, e.g. the limitation to English is not only pragmatic but supported by 
citation. 
Heterogeneity of the included studies is always a potential problem for 
meta-analyses. The investigators have attempted to assess and control for 
heterogeneity statistically, and they report those results in the manuscript. 
A significant potential problem for clinical applicability of the reported 
studies is publication bias. A recent study ofthis phenomenon in self-
management education indicated that such bias not only exists, but is worst for 
GHb reporting in diabetes compared with other chronic diseases studied.42 Thus, 
Nonis et al. may be perfectly representative of the available literature, but not of 
the true effect of self-management education. This is a significant problem 
because although the point estimates would represent clinically significant 
changes, their confidence intervals range close to or beyond the null when follow 
up extends beyond a month. If relatively few negative studies have gone 
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unpublished, the data they represent could be enough to eliminate significant 
differences in the intervention groups. 
GROUP EDUCATION SETTING 
Rickheim et al. (2002)- RCT of education in a group versus individual setting.33 
Investigators recmited 170 patients referred to their Minneapolis, MN diabetes 
education center between April1997 and July 1999. Patient assignment was done 
initially in blocks of six, with the first three patients assigned to the intervention 
and the next three to the control group. Block size was expanded to ten after the 
first year. 
The intervention consisted of education delivered in a classroom format to 
groups of 4-8 patients. The initial session was 3 hours, with a 2 hour session at 2 i weeks and 1 hour sessions at 3 and 6 months. Control subjects received one-on-
one education in a 2 hour initial session and I hour sessions at 2 weeks, 3 months, 
and 6 months. A registered nurse and registered dietician delivered the education 
in all settings. 
The major outcome of interest for this review was HbA1,. Other measures 
included the Medical Outcomes Study short form 36 (SF-36) to assess global 
health-related quality of life, an adjustment-to-diabetes measure (ATT19), a 
satisfaction scale ( 4-point Likert) to assess patients' satisfaction with their control 
over diabetes, and self-reported measures of exercise and behavioral goal 
achievement. 
Results: There were no significant mean differences between groups on any of 
the parameters measured at 6 months. However, many before-and-after 
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measurements improved within groups. Most significantly, mean HbA1c in each 
group fell to 6.5% (from 9.0% in intervention, 8.2% in control). 
Assessment of Validity: The mechanism used to allocate patients to intervention 
and control groups was not sufficient to be random; this is exemplified by the 
difference in HbA1, between groups at baseline (intervention= 9.0 ± 1.6%, 
control= 8.2 ± 1.7%). Groups with such a significant difference in baseline 
control might well be different in other respects, and respond differently to 
educational interventions. 
Dropout rate was another significant possible problem. 92/170 patients 
completed the study at 6 months, for an overall attrition rate of 46%. There was 
also a large differential in dropout rate, with 44/87 (50.6%) of intervention 
patients failing to complete the study, compared to 34/83 (41.0%) of control I 
patients. The authors report that descriptive characteristics were similar to 
patients who completed the study, but these are not given. Investigators exclude 
dropouts completely from the analysis, although 72% of patients completed the 
study through 3 months. 
Despite substantial selection bias problems, this study does show highly 
significant decreases in HbA 1, for patients who completed either arm. This is 
probably enough to conclude that there is value in patient education generally, at 
least for patients who are willing and able to complete the intervention. More 
j 
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extensive follow up of these patients is warranted to see if the reported changes 
persist beyond the period of instruction. 
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For motivated external populations, structured education in either the 
group or individual setting is likely to improve patient HbAJc. Limitations for 
external validity include the requirement, based on this study, for an adherent 
patient population. The educators and physicians of the patients in this study 
were also highly trained in specific techniques of education for this setting and 
program, based on a complex theoretical model of behavior change and self-
management techniques. The availability of that training could limit the 
widespread application of such interventions. 
Trento et al.(2004, 2002)- Two reports of an Italian RCT involving a structured, 
comprehensive group education intervention versus the individual education 
delivered in the course of usual care34· 35 Investigators identified 112 patients 
from a database at their clinic in Torino, Italy and randomized 56 patients each to 
the intervention and control groups. Neither the random method by which they 
identified patients nor the one by which they allocated patients to treatment 
groups is reported. 
The intervention consisted of four sessions of group education, facilitated 
by 1-2 physicians and an educator, about diabetes with a systemic focus. The 
intervention was delivered in four sessions each in the first two years, in seven 
sessions in years 3 and 4, and re-started in year 5. The control group intervention 
is not explicitly defined in either of these two reports. Controls are referred to as 
"individual education and counseling", but this apparently refers to the routine 
counseling that investigators expect from the general primary care context. 
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Major physiologic outcomes included HbA1c, body mass index (BMI), and 
HDL cholesterol. Psychosocial outcomes included quality of life (diabetes 
quality oflife scale, DQOL), diabetes knowledge (Education Study Group of the 
Italian Society for Diabetes questionnaire, GISED), and problem solving skills 
(Condotte di Riferimento, CdR [custom instrument]) at five years. 
Results: The investigators found significant differences between groups at five 
years for %HbA1, (intervention= 7.3 ± 1.0, contro19.0 ± 1.6; p < 0.001) and 
weight (intervention 76.1 ± 12.9 kg, control= 77.3 ± 16 kg; p = 0.015). The 
HbA 1 c in the intervention group represented no change from baseline, while the 
control group value had increased. No other physiological parameters showed 
significant differences between groups. 
Problem solving ability, diabetes knowledge, and quality oflife scores 
were all better in the intervention group compared with the control (p<0.001 for 
all). 
Assessment of Validity: Overall, the quality of the study was fair. Between the 
two reports, reporting of some procedures was still inadequate, e.g. the precise 
mode of patient selection and randomization, and the exact procedure for controls, 
were not presented. This makes it difficult to assess potential confounders in the 
study. Although it seems unlikely that any single confounder would account for 
the maintenance ofHbA1, in the intervention group, we cannot be certain without 
the information. 
The major physiological outcomes that showed significant differences 
between groups were objectively and transparently measured. The study did not 
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mask primary care physicians or study personnel, but a confmmding relationship 
is difficult to imagine for the relevant parameters. 
The most significant threat to external validity is again the intensity of the 
intervention. Settings that are poor in personnel, financial, or time resources 
could not be expected to conduct this intervention. In addition, other than 
knowing that the population consisted ofitalians, we know little about the 
population characteristics. In other social contexts there may be significant social 
barriers to such intensive follow up. 
CULTURALLY COMPETENT EDUCATION 
Brown et a/.(2002)- RCT of education intervention targeted at Mexican 
Americans oflow socio-economic status living in Starr County, Texas36•43 
I Investigators selected patients from rosters of previous research studies. The total 
number of patients in the study is not clear from the report; the text and some 
figures indicate a total enrollment of 256 patients, but the flow diagram provided 
indicates a total enrollment of 502 patients. 
The study uses a nested design, in which some patients were wait-listed 
for one year while others received the intervention immediately. The authors also 
refer to experimental vs. control groups, and it is not clear whether these are the 
same as the treatment vs. control groups and treatment vs. wait-listed groups 
referenced throughout the text. 
Randomization by undescribed means occurred in blocks of 64 patients on 
a quarterly basis, with half going to treatment and half to wait-listed groups. The 
patients who received the experimental intervention received an intensive 
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program that included 3 mouths of weekly The providers were all bilingual 
(English and Spanish) and Mexican American, and were nurses, dieticians, and 
community workers. The intervention occurred in clinics, but also in schools, 
churches, offices, and adult day care centers. The approach attempted to 
incorporate culturally competence in language, food choice, health beliefs, and 
family participation. 
Major physiologic outcomes were HbA1,, fasting blood glucose (FBG), 
total cholesterol, triglycerides, and body mass index (BMI). Health beliefs and 
diabetes knowledge were also assessed. 
Results: FBG and HbA 1, were the only physiological parameters that were 
significantly changed during the course of the intervention. The authors used 
statistical modeling to estimate a growth curve for each parameter, which allowed 
them to incorporate all measurements, even for patients who left the study. By 
this analysis, there was a significant change over time in HbA1, between groups 
(coefficient -0.07, SE 0.03, p=0.016). However, in the reported adjusted means, 
there was a significant difference between HbA1, between groups only at 6 
months, which was no longer significant at 12 months. The absolute values of 
HbA1, in both groups remained very high at 12 months (intervention= 10.64%, 
control= 11.20%). 
Diabetes knowledge was also higher in the experimental group at 12 
months (test score intervention group= 43.15, control= 40.78; p < 0.001). 
Assessment of Validity: Selection bias is a potential problem for this study 
because the source population is derived from people who have already 
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participated in other studies. Although the authors state that none of the other 
studies involved interventions, it is still likely that there is a very strong volunteer 
bias, because all subjects are willing to participate in at least two research studies. 
The mode of selection is also obscured- we do not know whether the random 
selection was done by the investigators or another person, or by what means (e.g. 
paper lists, computerized selection). 
The statistical modeling in the study is presented as a strength, and it is to 
the extent that it attempts to reduce selection bias caused by dropouts. However, 
given the data for patients who completed the trial, the statistical modeling may 
be a weakness. The adjusted mean HbA1c values at 3, 6, and 12 months show that 
the experimental group was in better glycemic control at 6 months, but that there 
was statistically no difference between the groups by one year, although the 
intervention was ongoing. Dropouts whose trend toward control changed late in 
the year may not have that change represented in the model. 
Contrary to the claims of the authors, this study appears to be essentially 
negative. The statistical models may show some trend toward improvement from 
the intervention, but that trend is not reflected in the physiologic measure of 
control reported at one year. In addition, even if the growth curve data is correct 
and there is some intervention effect, the absolute effect is not sufficient to lower 
mean HbA1, even below I 0%. 
EXPERIENCE-BASED EDUCATION 
Sarkadi et a/.(2004)- RCT of pharmacist-led, experience-based group education 
for patients with type 2 diabetes in Sweden37 The researchers recruited 84 
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patients through advertising, of whom 77 entered randomization. Patients were 
required to have a diagnosis of type 2 diabetes and not to have been treated with 
insulin for more than two years. 
The randomization process was highly unconventional, and involved 
office personnel making piles of envelopes out of a box. Patients were assigned 
to either the intervention or to a 2-year waiting list (the control). The intervention 
consisted of monthly meetings led by a pharmacist, at which patients discussed 
practical ways to deal with diabetes. Intervention subjects also received diaries to 
fill out between meetings, and shared experiences from these at meetings. The 
intervention ended after twelve months, with the final assessment performed one 
year after that. 
Results: There was a significant difference between groups in HbA1, at 6 months 
(intervention= 5.5%, control= 6.3%; p<0.05) and 24 months 
(intervention= 6.2%, control= 6.6%; p<O.Ol), but not at 12 months. 
Assessment of Validity: The randomization scheme for this study was not 
adequate. The failure of randomization appears as a significant difference in 
length of diabetes at baseline between groups, with intervention patients having, 
on average, more than twice the duration of disease (intervention= 5.9 vs. 
control= 2.6years). The cohort in general is highly selected and at baseline has 
exceptional glycemic control, with more than half of participants having HbA1, 
values < 6.5%. 
The authors never adequately explain a theoretical or practical reason that 
the difference in HbA1, should disappear and subsequently reappear. No element 
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of their theoretical model can account for this unusual pattern. In any event, the 
investigators calculated their sample size to detect a 1% change in HbA1c, which 
their intervention did not produce. 
This study also has serious challenges to external validity. Their 
exceptionally well-controlled cohort is not likely to be reproducible in most 
settings. It is not clear from this study whether less motivated patients could reap 
any benefit from this kind of education. The idea that a received educational 
benefit could be absent immediately after the intervention and then reappear in 
one year's time is grossly counterintuitive, and needs to be further explained 
before such an intervention is tried in other settings. 
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Appendix 2: Evidence Table 
Intervention Patient Education Category: 
First Author Brown SA 
Other authors Garcia A/\, Kouzekanani K, Hanis CL 
Title Culturally competent diabetes self-management education for Mexican Americans 
Journal Diabetes Care 
Year 2002 
Study Design RCT 
Self-management education (3 month weekly 2-hr sessions, 6 month biweekly, 3 month 
Intervention monthly 2-hr support sessions}, adjusted for Texas-Mexico border cultural setting vs. wait-list 
control 
Inclusion Criteria type 2 DM diagnosis after age 35, live in Starr County, TX; 35-70yrs old; 2 FBG>l40mg/dl OR I+ year history or oral hypoglycemic therapy; willing to participate 
Exclusion Criteria pregnant; any medical condition in which diet or exercise change was contraindicated 
Initial Sample Size 502 
Dropouts 68 
Final Sample Size 502 
Characteristics of No 
Dropouts Noted? i 
Addresses 
Selection Bias ++ 
Selection Bias dropouts included using statistical modeling; potential volunteer bias 
Comments 
Primary Outcome OM-related knowledge, health beliefs, Ale, f'BG, lipids, BMI 
Measure 
Other Outcomes 
Addresses +++ 
measurement bias 
Measurement Bias 
objective or validated measures taken Comments 
Addresses ++ 
Confounding 
Confounding 
no description of randomization; no significant differences in reported baseline characteristics Comments 
Overall Results grmvth curve differences in Ale between groups; no statistically significant differences in 
means at]? months; statistical "over time" difference 
Overall Internal Fair Validity Rating 
Internal Validity inclusion of dropouts and use of valid measures sound methodology 
Comments 
External Validity Result probably applicable to other Mexican American populations \Vith poor glycemic 
control; possible extension to other non-English speaking immigrants, but other cultural 
Comments considerations make this more complicated 
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Intervention Patient Education Catc~ory: 
First Author NolTis SL 
Other authors Lau .1, Smith SJ, Schmid CH, Engelgau MM 
Title Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control 
Journal Diabetes Care 
Year 2002 
Study Design meta-analysis 
Intervention systematic review of English language trials of self-management education 
English language, RCT, most subjects had type 2 OM, ages >18, reported glycosylated 
Inclusion Criteria hemoglobin as outcome, included in MEDLINE, CINAHL or ERIC databases between 1980 
and 1999, matched 
Exclusion Criteria MESH headings "health education" and "diabetes mellitus" or hand-search Abstracts, dissertations, non-RCT 
Initial Sample Size 0 
Dropouts 0 
Final Sample Size 31 
Characteristics of No 
Dropouts Noted? 
Addresses Selection 
+++ 
Bias 
Selection Bias 
explained rationale for English-only papers and RCTs Comments 
Primary Outcome GHb, stratified by follow up period Measure 
Other Outcomes none 
Addresses 
++ 
measurement bias 
Measurement Bias reliant on various investigators, but used objective, standard measure and described 
Comments conversion when used 
Addresses 
++ 
Confounding 
Confounding publication bias could be an issue favoring positive results for the literature in this period Comments 
Overall Results GHb changed -0_76 [ -1.18 to -0.34l(immcdiatc), -0.26 [-0.73 to 0.21 ](1- 3 month), -0.26 [-0.48 to +0.05](4+ months) 
L 
Overall Internal Good Validitv Rating 
Internal Validity Study is methodologically sound and explained in detail Comments 
External Validity Use of a wide variety of studies and settings favors applicability in various situations. 
Comments Possibility of publication bias casts doubt, but in settings with adequate resources these 
otherwise hannless interventions are f3.vored by this evidence 
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Intervention Patient Education Catco-ory: 
First Author Polonsky WI-J 
Other authors Earles J, SmithS, Pease DJ, Macmillan M, eta/. 
Integrating medical management with diabetes self-management training: a randomized 
Title control trial of the Diabetes Outpatient Intensive Treatment program 
Journal Diabetes Care 
Year 2003 
Studv Design RC'T 
Intervention 3- day DOlT (vs. EDUPOST) OM education 
Inclusion Criteria Pts from Tripier Army Med Center (HI); Type 1 OR 2OM; Ale> 8.5% in last 3mos; 
contacted by mail, by phone, through providers, and advertisements in hospital 
Exclusion Criteria none listed 
Initial Sample Size 196 
Dropouts 29 
Final Sample Size 167 
Characteristics of No 
Dropouts Noted? 
Addresses Selection 
++ 
Bias 
Selection Bias significant dropout rate; more likely to drop out of control (EDUPOST) group; analysis done 
Comments only ofl67 who completed baseline packet (of 196 randomized) 
Primary Outcome HbA 1 cat 6 months 
Measure 
Other Outcomes modified Summary of Diabetes Self Care scale 
Addresses 
++ 
measurement bias 
Measurement Bias Modified scale has not been independently validated; Ale is objective outcome Comments 
Addresses 
+++ Confoundino-
Confounding Randomized design worked based on Table 1 (baseline char); some pts did not complete all 
Comments f/u, but analysis done with and without that data to acct for differences 
DOlT A 1 c dropped more than EDUPOST (2.3 vs. 1.7%, p<0.02); reported improvement in 
Overall RestJits self-care behaviors BGM and ACFC but not following meal plan or exercise ; more fi'u 
contact produced better Ale among DOlT pts 
Overall Internal Fair Validity Ratinu 
Internal Validity Ale change over 6 months, but \vould like to see longer f/u Comments 
External Validity Intervention was highly intensive and may not be practical in settings where resources of 
Comments time, money, or personnel are limited 
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Intervention Patient Education Category: 
First Author Rachmani R 
Other authors Slavachevski I, Berla M, Frommer-Shapira R, Ravid M 
Teaching and motivating patients to control their risk factors retards progression of 
Title cardiovascular as well as microvascular sequelae of type 2 diabetes mellitus- a randomized 
prospective 8 years follow- up study 
Journal Diabetic Medicine 
Year ?005 
Study Design RCT 
Intervention 2 hour infOrmational/motivational session vs. usual care 
Inclusion Criteria type 2 DM (diagnosis age 40+), HTN> 140/90, hyperlipidemia (LDL> 120), referred to DM 
outpatient clinic Mcir Hasp (Israel); recruited (volunteers) 
Exclusion Criteria age <45 or>70; smoker; BMf>35; CR>2; alb/Cr>200mg/g; history CVA, MI, angina, 
vascular surgery, malignancy, liver disease, autoimmune disease, or life expectancy <5 years 
Initial Sample Size 141 
Dropouts 12 
Final Sample Size 141 
Characteristics of No Dropouts Noted? 
Addresses Selection 
++ 
I 
Bias 
Selection Bias Coh01t is same as Rachmani et al, 2002 Comments 
Primary Outcome CVDE index- all CVD events Measure 
Other Outcomes e-GFR 
Addresses 
++ 
measurement bias 
Measurement Bias 
post hoc primary outcome; some measures have potential reporting bias (eg Ml) Comments 
Addresses 
+++ 
Confoundine 
Confounding Randomization was adequate in original t1ial; groups have apparently nondiffcrential 
Comments dropout- if this is so, confounders should still be evenly distributed between groups 
Overall Results all non-fatal CVD events, and subgroups stroke and CABG+PCf were significantly lower in PP; e- GFR continued to be better 
Overall Internal Fair Validitv Ratine 
Internal Validity 
other than post hoc identification of primary outcome, this study is methodologically sound Comments 
External Validity probably needs motivated population; unclear how \vould translate to less homogeneous pop, 
Comments but intervention is very brief & not very resource-intensive tOr consultant (may be somewhat for PCP) 
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Intervention Cateeorv: Patient Education 
First Author Rachmani R 
Other authors Levi Z, Slavachevski !, Avin M, Ravid M 
Teaching patients to monitor their risk factors retards the progression of vascular 
Title complication in high-risk patients with type 2 diabetes mellitus- a randomized prospective 
study 
Journal Diabetic Medicine 
Year 2002 
Study Design RCT 
Intervention std annual consultation (SC) or pt pm1icipation program(PP) over 
Inclusion Criteria type 2 DM (diagnosis age 40+), HTN> 140/90, hyperlipidemia (LDL> 120), referred to DM 
outpatient clinic Mcir Hasp (Israel); recruited (volunteers) 
age <45 or >70; smoker; BM!>35; CR>2; alb/Cr>200mglg; history CVA, Ml, angina, 
Exclusion Criteria vascular surgery, malignancy, liver disease, autoimmune disease, or life expectancy <5 
years 
Initial Sample Size 141 
Dropouts 12 
Final Sample Size 129 
Characteristics of No 
Dropouts Noted? 
Addresses Selection 
Bias 
++ 
Selection Bias allocation by random#- unclear whether was paper table or computerized; highly selected 
Comments group with short disease duration, nonsmoker, low BMI 
Primary Outcome change in renal function (e-GFR and change in urinary alb/Crratio; change in BP, LDL, 
Measure Hbi\ 1 c 
Other Outcomes None listed 
Addresses measurement 
+++ 
bias 
Measurement Bias highly standardized, objective measurements well-explained Comments 
Addresses Confounding ++ 
Confounding PCPs unaware of allocation, randomization was by acceptable method & baseline 
Comments characteristics indicate it was successful 
Overall Results PP group has better renal function by all measures at end of study 
Overall Internal Fair 
Validity Ratin~ 
Internal Validity Well-done study with standardized, objective outcomes and well-described, apparently 
Comments valid methods 
External Validity Highly selected group. Less intensive intervention that worked with existing care, 
Comments although authors did see pts. Suspect would need some\vhat empowered patients for 
success 
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Intervention Cate2orv: Patient Education 
first Author Rickheim Pl. 
Other authors Weaver TW, flader JL, Kendall DM 
Title Assessment of group versus individual diabetes education: a randomized study 
Journal Diabetes Care 
Year 2002 
Studv Design RCT 
Intervention 5-7 hrs Group (4-8 pt) diabetes education vs. 4 sessions of individual education at 0, 2wks, 12weeks and 24 weeks 
Inclusion Criteria type 2 diabetes; recruited between Apri11997-July 1999; referred to OM education center in Minneapolis; age 30-SOyrs; willing to pa1iicipate in study 
Exclusion Criteria language barrier; mental disability 
Initial Sample Size 170 
Dropouts 78 
Final Sample Size 92 
Characteristics of No Dropouts Noted? 
Addresses Selection 
++ 
Bias I 
Selection Bias referral bias- unclear who gets referred to education center; sequential patients; high 
Comments 
att1ition rate (46%) differential for intervention (44 patients from intervention, 34 from 
control) 
Primary Outcome tested knowledge, self-reported exercise freq and duration; goal achievement 
Measure 
Other Outcomes hbal c, BMI, weight, SF-36, adjustment to diabetes instrument (ATT19), satisfaction (4-pt Likert) survey 
Addresses measurement 
++ 
bias 
Measurement Bias 
outcomes of interest for review objectively measured; validated scales including SF-36 
Comments 
Addresses Confounding ++ 
Confounding Comments poor randomization scheme cannot eliminate confounders; baseline Ale higher in interventiOn group 
no differences between groups in changes of any parameter except AI c; this parameter 
Overall Results changed more in intervention group, but \Vas higher at baseline and probably has !1oor 
effect 
Overall Internal Fair Validity Rating 
Internal Validity selection is a problem, with poor randomization by face validity of the scheme and indicated by difference in A 1 c at baseline and with large overall and dif!Crcntial dropout 
Comments rate 
External Validity Among patients who adhere to the program, either group or individual education is likely 
Comments to produce significant changes in physiological parameters 
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Intervention Category: Patient Education 
First Author Sarkadi A 
Other authors Rosenqvist U 
Title Experience-based group education in type 2 diabetes: a randomized controlled trial 
Journal Patient Education and Counseling 
Year 2004 
Study Desien RCT 
Intervention pharmacist-led education intervention lasting one year 
Inclusion Criteria type 2 DM, not treated with insulin OR insulin< 2ycars, 
Exclusion Criteria None listed 
Initial Sample Size 77 
Dropouts 13 
Fin.al Sample Size 64 
Characteristics of No Dropouts Noted'? 
' r 
Addresses Selection 
Bias ++ I 
Selection Bias Highly unusual randomization process cannot insure adequate randomi:zation; strong 
Comments volunteer bias indicated by low baseline HbAlc (6.5%) 
Primary Outcome HbAlc at 6,12,24 months 
Measure 
Other Outcomes None 
Addresses 
measurement bias +++ 
Measurement Bias Objective, standardi.zcd measurement reduces risk of bias Comments 
Addresses 
++ 
Confounding 
Confounding greater duration of diabetes in intervention group (5.9 vs. 2.6 yrs) show inadequate 
Comments randomization 
Overall Results intervention group had significantly lower HbAic at 6 and 24 months, but not at 12 months 
Overall Internal Fair Validitv Ratino 
Internal Validity Randomization insutlicient; strong volunteer bias Comments 
External Validity highly selected population, relatively simple intervention may not be as effective in less 
motivated patient group; resources to train pharmacists and maintain training may be scarce Comments in other settings 
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Intervention Patient Education Category: 
First Author Trcnto M 
Other authors Passera P, Bargo E, Tomalino M, Bajardi M, Cavallo r, Porta M 
Title A 5 year randomized controlled study of learning, problem solving ability, and quality of life 
modifications in people with type 2 diabetes managed by group care 
Journal Diabetes Care 
Year 2004 
Study Design RCT 
Intervention group education vs. individual care and education 
Inclusion Criteria type 2 diabetes not treated by insulin, age <80 and >I year; in database of clinic in Turin 
Exclusion Criteria insulin use 
Initial Sample Size 112 
Dropouts 28 
Final Sample Size 84 
Characteristics of No 
Dropouts Noted? 
Addresses Selection 
++ 
Bias 
Selection Bias 
target population is not well described; dropout is nonditlhential between groups Comments 
Primary Outcome HbA!c, BMI, HDL, quality oflife, knowledge, problem solving 
Measure 
Other Outcomes None reported 
Addresses 
++ 
measurement bias 
Measurement Bias control intervention poorly described; QOL, knowledge, problem solving assessed by 
Comments questionnaire- don't know where or how given, or by whom 
Addresses 
++ Confounding 
Confounding randomization not described here, and baseline characteristics differed in that intervention 
Comments patients were less educated than controls 
Overall Results significant differences in A 1 c, problem solving, QOL, at 5 years 
Overall Internal 
rair Validity Ratin_g 
Internal Validity some aspects oft he trial were properly done but reported elsewhere (e.g. more detailed protocol; random method of initial patient selection and group allocation are not described, 
Comments and randomization \vas flawed based on education parameter 
External Validity In settings where individual education is currently being used, this study provides some 
evidence that a group approach may be superior. Direct contradiction to Rickheim ct a!-Comments unclear whether the difference is methodological or socio-cultural 
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Intervention Cateoory: Process of Care 
First Author California Medi-cal Study Group 
Other authors none 
Title minority populations 
Journal Diabetes Care 
Year 2004 
Study Design RCT 
Intervention diabetes case management vs. usual care ' 
Inclusion Criteria type 2 diabetes fOr at least 1 year;> 18yrs of age, attend Medicaid clinical sites in 
southern CA, 
Exclusion Criteria Ale< 7 .5, serious diabetes-related complications, serious medical conditions 
Initial Sample Size 362 
Dropouts 41 
Final Sample Size 321 
Characteristics of No 
Dropouts Noted'? 
Addresses Selection Bias ++ 
Selection Bias Comments because all eligible patients are included, volunteer bias and bias from dropouts are largely avoided 
i 
Primary Outcome 
serial HbAlc every 6 months over mean 25.3 months 
Measure 
Other Outcomes 
Addresses measurement 
++ 
bias 
Measurement Bias all patients with at least one follow up I lbA I c included; primary care providers not 
Comments masked 
Addresses Confouncling +++ 
Confounding Comments statistically accounted for rapid initial drops in A I c by adjusting model to account for this effect in dropouts; 
Overall Results 1\t every time point except baseline Hb/\ 1 c was lower in intervention group 
Overall Internal Validity Fair Rating 
Internal Validity inclusion of dropouts in ITT analysis and accounting for shape of HbA 1 c curve improve 
Comments effectiveness determination 
External Validity intensive, population characteristics make this likely intervention for other sites, 
Comments especially with low socioeconomic status or high %immigrant population 
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Intervention Process of Care Category: 
First Author DiLoreto C 
Other authors Fanelli C, Lucidi P, Murdolo G, De Cicco A, Parlanti N, Santeusanio F, Brunetti P, DeFeo P 
Title Validation of a counseling strategy to promote the adoption and the maintenance of physical 
activity by type 2 diabetic subjects 
Journal Diabetes Care 
Year 2003 
Study Design RCT 
Intervention 30 min structured physician counseling+ telephone and office ffu vs. usual care 
Inclusion Criteria 2 months of consecutive pts referred to [tali an hospital endocrine dept; t2DM diagnosis for at least 2yr; age 40+; 
Exclusion Criteria cardiac, liver, or renal failure; any disease that "could seriously reduce" life expectancy 
Initial Sample Size 340 
Dropouts 3 
Final Sample Size 337 
Characteristics of Yes 
Dropouts Noted? 
Addresses Selection 
++ 
Bias 
Selection Bias Convenience sample of consecutive patients, but large and over relatively long time may 
Comments help make representative 
Primary Outcome target energy expenditure at 2 yrs 
Measure 
Other Outcomes HbAlc, BMI 
Addresses 
++ 
measurement bias 
Measurement Bias No allocation concealment, but [3M\ and A I care objectively measured, self-report of primary 
Comments outcome 
Addresses 
++ 
Confounding 
Confounding Randomization scheme uncertain; not described; reported baseline criteria were the similar 
Comments 
Average energy expenditure higher in intervention group (27.1 vs. 4.1 MET-hrs) at 2 yrs; 
Overall Results more pts above target of IOMET-hr (69% vs. 18%); intervention BMI was 10\ver than 
baseline, while control higher at 2 yr (28.9 vs. 30.4); A lc down to 7.0 (vs. 7.6) 
Overall Internal fair Validity Rating 
Internal Validity Long follow up, randomized design, and large effect size overcome some issues of 
measurement inherent in the type of intervention; rcfen·al bias may affect external validity; 
Comments walking groups maybe not practical in non-urban areas 
External Validity Intervention presents somewhat intensive demand on physician time; pts refetTed to this 
Comments clinic may be more motivated than general patient 
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Intervention Cateoorv: Process of Care 
First Author Goldhaber-Fiebert JD 
Other authors Goldhaber-Fiebert SN, Tristan ML, Nathan DM 
Title Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in diabetic patients in rural Costa Rica 
Journal Diabetes Care 
Year 2003 
Study Design RCT 
Intervention 11 weekly 90 min nutrition classes and Jx weekly 60 min walking groups for 12 weeks 
vs. standard medical care 
Inclusion Criteria Type 2 diabetes, recruited from list at local hospital, social worker contacts, and public 
advertising; pts tfom 3 local rural towns 
Exclusion Criteria No volunteers excluded 
Initial Sample Size 75 
Dropouts 0 
Final Sample Size 61 
Characteristics of No 
Dropouts Noted? 
Addresses Selection Bias ++ 
Selection Bias Comments Volunteer bias; refenal bias- pts not already "in the system" likely to be missed using these recruitment tactics; mostly women subjects 
Primary Outcome Weight, height, BP, GHb, FPG, lipids 
Measure 
Other Outcomes None reported 
Addresses measurement 
++ 
bias 
Measurement Bias PCPs and lab technicians masked; standard, objective, common measures; should have 
Comments reported absolute values as well as changes in outcomes 
Addresses Confoundine: ++ 
Confounding Comments Uncertain randomization scheme; medication changes and clinic visits similar between groups 
Overall Results Repmted as changes: BMI -0.4 vs. +0.2; GHb -1.8 vs. +0.4; lipids and BP no significant 
changes 
Overall Internal Validity fair 
Rating 
Internal Validity Allocation concealed where possible; <20% attrition; randomization should be described 
Comments 
External Validity Intervention in rural Costa Rica may not be directly transferable to other populations, but 
Comments these relatively simple measures should be adaptable to other situations 
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Intervention Process of Care 
Category: 
First Author New JP 
Other authors Mason JM, Frccmantlc N, Teasdale S, Wong LM, Bruce NJ, Burns JA, Gibson JM 
Title Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetcs(SPLINT) 
Journal Diabetes Care 
Year 2003 
Study Design RCT 
Intervention nurse-led clinics every 4-6 weeks directed at HTN & hyperlipidemia 
Inclusion Criteria Either SBP >140 mmHg or DBP > 80 mmHg, or total cholesterol >5mmoi/L (193 mg/dL); 
registered in Salford electronic diabetes register tOr shared care at Hope Hospital 
Exclusion Criteria None noted 
Initial Sample Size 1407 
Dropouts 0 (all enrolled patients included in analysis) 
Final Sample Size 1407 
Characteristics of Yes 
Dropouts Noted? 
Addresses Selection 
+++ I 
Bias 
Selection Bias 80% type 2 diabetes 
Comments 
Primary Outcome OR ofpts achieving targets (BP <140/80; total cholesterol <Smmol/L) 
Measure 
Other Outcomes mortality, ORs for subgroups 
Addresses 
+++ 
measurement bias 
Measurement Bias 
objective measures taken by masked clinicians 
Comments 
Addresses 
+++ Confounding 
Confounding Randomization occurred remotely at a central service, stratified by patient's primary general practice. Each condition randomized separately, and eligible pts were randomized twice. ITT 
Comments analysis including dropouts as failing to reach targets 
Overall OR 1.37 (l.ll-1.69, p 0.003) in favor of intervention; lipid only OR 1.69 ( 1.25-
Overall Results 2.29,p=0.0007); BP only not significant OR 1.14 (0.86-1.51, p=0.37); mortality OR 0.55 
(0.32-0.92 p~0.02) 
Overall Internal fair Validitv Rating 
Internal Validity Masking, randomization, and measurement were all methodologically sound. Outcomes 
Comments defined before study. Both positive and negative subgroup analyses are reported 
External Validity availability of resources could be problem; transfer to di!Tcrcnt social context and medical 
Comments systems could be effective if nurses come from same context 
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Intervention Cateeorv: Process of Care 
First Author Pouwer F 
Other authors Snoek FJ, van der Ploeg HM, Ader HJ, Heine RJ 
Title Monitoring of psychological well-being in patients with diabetes 
Journal Diabetes Care 
Year 2001 
Studv Design RCT 
Intervention standard care (q3-4month visit) vs. s.c. +psychological monitoring program w/ std questionnaire, both over 12 months 
Inclusion Criteria Over 18 years old, pt at Amsterdam outpatient DM clinic, EITHER type DM; sent letter 2wks before appt 
Exclusion Criteria visual or language problems that could prevent questionnaire usc; 
Initial Sample Size 400 
Dropouts 55 
Final Sample Size 345 
Characteristics of No Dropouts Noted? 
Addresses Selection 
++ 
Bias 
Selection Bias Comp-gcncrated random number allocation; visual exclusion may eliminate some severe 
Comments DM; non differential dropout rate with reasons for dropping but no characteristics reported 
Primary Outcome Mood (by computerized W-BQx3 [office], SF-36xl [home]), HbA 1 c 
Measure 
Other Outcomes patient evaluation of quality of OM-related care(PEQD x 2 at home) 
Addresses measurement 
+++ 
bias 
Measurement Bias 
used standardized tools; explained power calculation 
Comments 
Addresses Confoundin~ ++ 
Confounding after randomization, high dropout rate attributed to: moving, "too time consuming" (18 
Comments pts), 10 died; no indication of which groups contained which dropouts; could confound 
Overall Results monitoring higher in study group 
Overall Internal 
Validity Rating Fair 
Internal Validity Outcomes valid; concern with selection bias rc: dropouts 
Comments 
External Validity from the intervention that didn't seem effective in this study- further study in populations 
Comments would be required 
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Intervention Catee:ory: Process of Care 
First Author Rothman RL 
Other authors Malone R, Bryant B, Shintani AK, Crigler 8, Dewalt DA, Dittus RS, Weinberger M, Pignone MP 
Title A randomized trial of a primary care-based disease management program to improve 
cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes 
Journal The American Journal of Medicine 
Year 2005 
Studv Desie:n RCT 
Intervention phannacist-led primary care-based disease management program 
Inclusion Criteria type 2 DM, HbAI c>8.0, > 18yrs, speak English, life expectancy> 6 months 
Exclusion Criteria 
Initial Sample Size 217 
Dropouts 13 
Final Sample Size 204 
Characteristics of Yes 
Dropouts Noted'? 
Addresses Selection 
++ 
Bias 
Selection Bias 
random-number generator; sealed envelopes; assigned after initial education session 
Comments 
Primary Outcome 8P, A 1 c, aspirin use at 6/12 months; lipids at 12 months 
Measure 
Other Outcomes DM knowledge, satisfaction, use of clinical services, adverse events 
Addresses 
+++ 
measurement bias 
Measurement Bias 
objective measures; nurses blinded to allocation 
Comments 
Addresses Confounding ++ 
Confounding good randomization scheme, well-described, but some baseline characteristics still different between groups; addressed problem by statistical adjustment, which produced Comments 
similar outcomes 
Overall Results SBP diff= 5mmHg p=0.02; HbAl c -1.6 vs. -2.5%, diff= 0.8% p=0.05; cholesterol no difference; aspirin use ctrl 58% intervention 91% p<O.OOO I 
Overall Internal Fair Validity Rating 
Internal Validity Despite apparent failure of randomization, the study is methodologically sound, and there 
Comments is little reason to believe the significant outcomes are due to faulty randomization 
External Validity Similar patients should be easy to find and should benefit in other settings; use of 
Comments pharmacist practitioners is intensive & may not be feasible in all settings. 
82 
Intervention Process of Care Category: 
First Author Sane H 
Other authors Akanuma Y, Yamada N 
Title Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year interim report 
Journal Harm Mctab Res 
Year 2002 
Study Design RCT 
Intervention intensive lifestyle management in person and by phone 
Inclusion Criteria type 2 DM, HbAlc > 6.5%, urine albumin< 150mg/g Cr; 
serum Cr > I.Jmg/dL; angina pectoris, ischemic cerebral vascular events, arteriosclerosis 
Exclusion Criteria obliterans, familial hypercholesterolemia, type Ill hyperlipidemia; history of intra-ocular 
surgery or non-diabetic nephropathy, nephrotic syndrome 
Initial Sample Size 2205 
Dropouts 232 
Final Sample Size 1973 
Characteristics of No 
Dropouts Noted? 
Addresses Selection ++ 
I 
Bias 
Selection Bias 
mode of recruitment not clear; dropouts few and balanced 
Comments 
Primary Outcome l-Ib A 1 c at 3 years 
Measure 
Other Outcomes serum triglycerides, plasma insulin, 1-/DL cholesterol; plasma c-peptide 
Addresses 
+++ 
measurement bias 
Measurement Bias 
standard assays nationwide of objective measure 
Comments 
Addresses ++ 
Confounding 
Confounding No notable confounders reported; randomization method not described at all; baseline 
Comments biophysical characteristics are similar between groups 
small but statistically significant differences between groups in HbA 1 cat three years; no 
Overall Results other difference between groups, but improvements in I-IDL, plasma insulin, and serum TG 
within both groups 
Overall Internal Fair Validity Rating 
Internal Validity Provides enough information to assess the major outcome, but more description of 
Comments randomization and subject selection would strengthen further 
External Validity Cultural norms may play an important role for the success of this program in Japan. Similar 
Comments interventions should be studied in other settings before they are widely implemented 
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Intervention Category: Process of Care 
First Author Taylor CB 
Other authors Miller NH, Rilley KR, Greenwald G, Cunning D, Deeter A, Abascal L 
Title Evaluation of a nurse-care management system to improve outcomes in patients with 
complicated diabetes 
Journal Diabetes Care 
Year 2003 
Study Design RCT 
Intervention set goals with nurse-care manager, weekly group sessions for 4 weeks, regular phone calls to manage self-care vs. usual care 
Inclusion Criteria In Kaiser Permanente medical center database; HbAl c > 10%, at least 1 comorbidity determined by ICD-9 (hypertension, dyslipidemia, or CVD) 
non-English speaking; unwilling to participate; primary diagnosis ofCI-IF; <18 years old; 
Exclusion Criteria pregnant; enrolled in OM management clinic; lived too far away; deceased; no-show to 
baseline appt 
Initial Sample Size 169 
Dropouts 31 
Final Sample Size 127 
Characteristics of Yes 
Dropouts Noted? 
Addresses Selection 
++ 
Bias 
Selection Bias 
volunteer bias 169/341 eligible participated; patients already have access to care Comments 
Primary Outcome HbA l c, lipids, U/ A 
Measure 
Other Outcomes SF-36, Duke Activity Status; BDI; patient and physician satisfaction; medical utilization; process interventions including foot, eye, dental exam; flu shot; pneumovax shot 
Addresses 
+++ 
measurement bias 
Measurement Bias Measures are standardized and validated. Nurses could not be masked but took mainly 
Comments objective measures in standardized ways 
Addresses Confoundine; Randomization appears adequate 
Confounding baseline characteristics matched, although randomization not explained 
Comments 
Overall Results Only% patients meeting Ale goal was significantly different (24.6% control, 42.6% intervention; p<O.OJ) psychosocial measures not different 
Overall Internal Fair Validitv Ratine 
Internal Validity Significant dropout rate in addition to initial volunteer bias may have biased results in 
Comments favor of those who were succeeding 
External Validity 
motivated patients with access to care and poor control are likely to benefit 
Comments 
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Intervention Process of Care Cateeory: 
First Author Wagner ED 
Other authors Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, Coleman EA 
Title Chronic care clinics for diabetes in primary care 
Journal Diabetes Care 
Year 2001 
Study Desien RCT 
Intervention Group chronic care clinic vs. usual care 
age>30 yrs, pt in Seattle region of Group Health Cooperative ofPuget Sound; prefer those on 
Inclusion Criteria insulin or oral hypoglycemics; 36 pts randomly selected from each practice with 36 eligible 
pt' 
Exclusion Criteria terminally ill; demented or psychotic; unable to participate in study as determined by physician 
Initial Sample Size 1001 
Dropouts 294 
Final Sample Size 707 
Characteristics of No Dropouts Noted? 
Addresses Selection 
Bias + 
Selection Bias nonspecific exclusion by physicians, who were not blinded; random ID of 36 pts unspecified; 
Comments 65% pts never attended group session; 3 complete practices dropped out, and 3 changed physicians during study 
Primary Outcome health status via 3 SF-36 subscales 
Measure 
Other Outcomes process measures, Hba 1 c, total cholesterol, care usage & costs 
Addresses 
++ 
measurement bias 
Measurement Bias Collected from ad min. data systems & self-report questionnaires; SF-36 subscales not 
Comments independently validated for this kind of use; 
Addresses 
+ Confounding 
Confounding 
selection of patients by unmasked physicians may undermine randomization 
Comments L 
Overall Results less (intervcntion=31.5, ctrl=39.4 p=0.02) 
Overall Internal Fair Validity Ratine 
Internal Validity Main problem is with selection bias, including both initial selection and dropouts- cannot 
Comments determine whether this has contributed to largely negative study result 
External Validity HMO population may be representative of US cities, but multiple selection biases create doubt about the cohort that was analyzed. This mainly negative study can neither support not Comments rule out such an intervention for other patient groups 
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Intervention Setting of Care Category: 
First Author Denver EA 
Other authors Barnard M, Woolfson RG, Earle KA 
Title Management of uncontrolled hypertension in a nurse-led clinic compared with conventional 
care for patients with type 2 diabetes 
Journal Diabetes Care 
Year 2003 
Study Design RCT 
Intervention Nurse-led 1-ITN clinic (vs. usual care) 
Inclusion Criteria Type 2 DM, previously diagnosis HTN currently> 140/80 under treatment, adults, Whittington Hospital London UK; 
Exclusion Criteria "serious or life-threatening conditions requiring intensive management"; renal complications 
were allowed in with different target 
Initial Sample Size 120 
Dropouts 5 
Final Sample Size 115 
Characteristics of No Dropouts Noted? 
Addresses Selection 
+ 
Bias 
Selection Bias Pts selected "randomly" by investigators from their populations (unknown means), alternate 
Comments pts to each intervention- unknown who allocated 
Primary Outcome 
change in BP at 6 months 
Measure 
Other Outcomes changes in stroke/CHD risk ,Total cholesterol, 1-!DL, TG, HbAlc, UAE (albumin), Cr, scores 
at 6 months 
Addresses 
+++ 
measurement bias 
Measurement Bias BP protocol very specific; other physiologic measurements Comments 
Addresses 
Confoundine ++ 
Confounding Unclear how often control group saw provider; effect could be from frequency of visits (process) rather than NLC setting. randomization produced a treatment group \Vith Comments 
significantly higher BMI and 10- yr CHD risk at baseline 
Overall Internal Fair Validity Rating 
Internal Validity Selection bias and confounders cloud clinically significant drop in blood pressure 
Comments 
External Validity Protocol is intensive & may not be practical in lower-resource or decentralized contexts. Also, without knowing freq of CPC visits, we cannot say whether NLC would be helpful for Comments those with already high freq flu 
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Intervention Setting of Care Category: 
First Author SmithS 
Other authors Bury G, O'Leary M, Shannon W, Tynan A, Staines A, Thompson C 
Title The north Dublin randomized controlled trial of structured diabetes shared care 
Journal Family Practice 
Year 2004 
Study Design RCT 
Intervention multifaceted DM intervention including nurse specialist clinics, local clinic guidelines, 
appointments every 3 months, record cards- randomized at practice level 
Inclusion Criteria At level of physician (GP)- GPs drav.m from voluntary database {sample size expressed in GPs); patients> 18 yrs, type 2 diabetes for at least 1 yr, 
Exclusion Criteria None noted 
Initial Sample Size 183 
Dropouts 0 
Final Sample Size 183 
Characteristics of Yes 
Dropouts Noted? i 
Addresses Selection 
++ 
Bias 
Selection Bias 
volunteer bias by physicians nondifferential and biases toward null; patients 
Comments 
Primary Outcome HbAlc 
Measure 
Other Outcomes BP, BMI, smoking, satisfaction and well-being scores, process outcomes 
Addresses 
++ 
measurement bias 
Measurement Bias processes reported by GPs and patients- strong potential recall bias; all A 1 c were done in 
Comments same lab 
Addresses 
++ Confounding 
Confounding practice randomization occurred using random number table; done by independent researcher; participating practices tended to be solo and have no practice nurse than national average but 
Comments similar between groups 
Overall Results no difference in biophysical measures; diabetes well-being improved; patient-reported process not different; hospital and GP measured process outcomes better in intervention group 
Overall Internal Fair 
Validity Rating 
Internal Validity Validity for some process measures is highly subject to recall biases; t3.ilure to translate into 
Comments differences in glycemic control suggests some confounder 
External Validity This intervention may be applicable to varied settings- use ofGPs mirrors primary care physicians in US, but an explanation of failure to affect HbAlc, BP, or lipids despite process Comments change is warranted before this intensive intervention is repeated 
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Appendix 3: Table of Excluded Studies 
De Berardis et al, 200444 Setting 
Brinkworth et at., 
200445 Process 
Keyserling et al., 200246 Educational 
Fanning et at., 200452 Setting 
Wen et al., 200453 Process 
Huang et at., 200454 Setting 
Rnilope et at., 200455 Process 
Boule et at., 200356 Process 
Cook et at., 2001 60 Setting 
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~ 
Prospective Cohort 
Poor overall quality 
Major outcomes did not 
match criteria 
Retrospective cohort 
Main intervention was 
Main outcomes do not 
meet inclusion criteria 
f 
" I 
~ 
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Appendix 4: Summary ofRCTs included in 2000 Cochrane 
review 
The Cochrane review regarding outpatient and community diabetes 
interventions, published in the year 2000, used somewhat broader inclusion 
criteria than the current review. The authors included 41 reports, of which 27 
were RCTs. Within the designs of the studies, some of the RCTs used before-an-
after time series or crossover designs for their clinical outcomes, or did not report 
outcomes relevant to this review. Ofthe RCTs presented in Renders et al., 11 
reported patient-related primary clinical outcomes relevant to the current review 
(i.e. HbA1,, blood pressure, blood lipids) with designs sufficient to minimize 
confounding and establish causation38 To provide the interested reader with the 
background and context of the current review, I include a short synopsis of the 11 
relevant RCTs included in that review65. 75 
Aubert 1998- process intervention study of 138 Jacksonville, Florida 
HMO patients with diabetes, in which nurse case managers followed locally-
developed treatment algorithms and made therapeutic recommendations to 
primary care physicians. Nurse case managers contacted intervention patients 
biweekly by telephone, provided patient education and educational materials, and 
helped to arrange follow-up appointments. Results: mean HbA1, at 12 months 
declined 1.7% in intervention group vs. 0.6% in usual care control group. No 
significant difference in BP or blood lipids was found between groups. 
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Carlson 1991- Setting of care study involving 4492 patients in 34 
Swedish health centers, with a subset of 566 patients participating in the HbA1, 
measurement that is our outcome of interest. The intervention involved locally 
developing and implementing processes of diabetes care by consensus, as well as 
providing professional education. Randomization was at the level of the practice. 
Results: despite improvements in process measures in the intervention group, 
mean HbA1, did not differ between groups. 
Hurwitz 1993- UK study of process interventions in 181 patients in 2 
hospital outpatient clinics, 38 community clinics, and 11 optometrists' offices. 
For the intervention, providers received educational meetings and implemented 
changes in medical record systems, including a centrally organized system for I prompting patients to return for follow up. Control clinics continued with their 
usual care practices. Randomization was at the level of the practice and median 
follow up was 2 years. Results: There was no difference between groups in any 
physiological variables, including mean %HbA1, and mortality at 2 years. 
Jaber 1996- Setting intervention study of 45 urban African-American 
patients in a single outpatient clinic. Intervention patients received all diabetes-
related care from a pharmacist, as well as additional pharmacist-led education, 
while controls continued to receive usual physician care. The intervention lasted 
4 months, with 39 of the patients participating at the conclusion of the study. 
Results: There was a significant improvement in glycated hemoglobin but not 
blood pressure in the intervention group. However, the sample size of 39 is very 
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small and Renders et al. caution that the study was not of the highest 
methodological quality. 
Kin month 1998- Process intervention trial of 41 English outpatient 
practices representing 250 patients, randomized at the level ofthe practice to the 
intervention or usual practices control group. The intervention consisted of 
providing physicians and nurses with professional education to improve skills in 
patient-centered care for patients newly diagnosed with type 2 diabetes. 
Measurement occurred at 12 months, at the end ofthe intervention. Results: 
Although some measures of communication were superior in the intervention 
group at 12 months, there was no difference between groups in HbA1,. The ! 
I intervention patients had higher mean BMI and serum triglycerides at 12 months than the control patients. 
Mazze 1994- Study of a setting intervention in Minneapolis, Minnesota, 
among 26 patients, randomized at the patient level. The comprehensive 
intervention involved Staged Diabetes management, consisting of: development 
of treatment guidelines locally by consensus; provision of educational sessions 
and materials to providers; and a system of reminders for aspects of patient 
treatment. Follow up was at 6 months. Results: The intervention group showed 
lower mean HbA1, in addition to improved process measures, but the 
investigators did not provide any statistical analysis or sufficient data to allow for 
-
readers to analyze the data on their own. 
Naji 1994- Study of setting changes among 3 practices (274 patients) in 
Grampian, UK. Investigators randomized patients to an integrated diabetes care 
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intervention or usual care control. Integrated diabetes care included: distribution 
of educational materials to providers; changes to the medical record system to 
generate reminders about patient care for providers; and improved arrangements 
for follow up to encourage patient visits every 3-4 months. Intervention patients 
also visited a central hospital clinic annually. Results: Investigators found no 
significant differences between groups in physiological parameters (HbA1,, BP), 
although costs may have been lower in integrated care. Authors report a 
differential dropout rate (intervention= 3%, control= 10%) 
Rutten 1990- Study of 149 patients randomized to usual care control or to 
a process intervention. The intervention focused on self-monitoring of blood 
glucose and implementation of a guideline that changed visit frequency according 
I 
• 
to success of metabolic control. The intervention lasted for one year, with 127 
patients completing the study. Results: Mean change in HbA1, was greater in the 
experimental group (-0.4%) than in the control (+0.5%), although baseline HbA1, 
was elevated in the experimental group (experimental= 9.7% vs. control= 8.9%) 
at baseline. The mean HbA1, at 12 months is therefore approximately the same 
between groups. 
Sadur 1999- Setting intervention in HMO in Northern California 
involving 185 patients with recent HbA1, > 8.5%. Intervention group patients had 
their physician providers replaced with multidisciplinary teams including a 
pharmacist, nutritionist, psychologist, and diabetes nurse educator. Teams saw 
patients in cluster visits and undertook formal case management, as well as 
providing additional patient education compared to usual care. The intervention 
92 
lasted 6 months. Results: The authors report that HbAlc levels declined by 1.3% 
in the intervention subjects versus 0.2% in the control subjects (p < 0.0001). 
Measures of self-efficacy and satisfaction also improved in the intervention 
group. 
Vinicor 1987- Process intervention trial among patients and medical 
residents at a general medicine clinic in Indiana. The intervention was 
implemented in a 2x2 design, with a control group, a resident education 
intervention, a patient education intervention, and a combined intervention with 
both resident and patients receiving education. The intervention lasted II 
months, with follow up continuing for an additional 26 months. Results: 
Investigators showed that patient education improved HbA1, and both systolic and 
diastolic blood pressure, while resident education improved HbA1, only, when i 
compared to the control group. The combined intervention produced even greater 
improvements in HbA1,, but in all groups hyperglycemia persisted. 
Weinberger 1995- Study of a process intervention in 275 Veterans L 
Affairs patients randomized to the intervention or to the usual care control. The 
intervention consisted of monthly nurse-initiated telephone contacts to provide 
patient education, reinforce compliance with regimens, monitor patients' health 
status, and facilitate access to primary care. The intervention lasted one year, 
with no further follow up beyond that time. Results: At the end ofthe study, the 
intervention group had significantly lower mean glycosylated hemoglobin 
(intervention~ 10.5% vs. control ~ 11.1 %, p ~ 0.046). However, the ultimate 
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clinical significance ofthis difference is not clear, because both groups still had 
severely elevated mean values. 
The studies included by Renders eta!. show that the state of the literature 
regarding outpatient interventions in diabetes care was similar in 2001 to its 
current state. Specifically, almost every trial reports a unique intervention, with 
little coordination in the types of intervention or the specific content of 
interventions within each broad type. Successful interventions that had been 
reported as of 2001 consisted mainly of resource-intensive case-management by 
nurses or by groups of allied health professionals. 
Methodological quality in this literature as of 2001 was also variable, even 
among included studies. Some of the brief descriptions above include caveats 
regarding validity so that the reader may have a more complete idea ofthe state of 
the literature. Detailed descriptions of potential threats to validity are available 
for the interested reader in Renders et az.3 8 
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